10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended September 30, 2014

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission file number 1-15477

MAXWELL TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Delaware	95-2390133
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
3888 Calle Fortunada, San Diego, California	92123
(Address of principal executive offices)	(Zip Code)

(858) 503-3200

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    YES  x    NO  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    YES  x    NO  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	¨	Accelerated filer	x
Non-accelerated filer	¨  (Do not check if a smaller reporting company)	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell Company (as defined in Rule 12b-2 of the Act).    YES  ¨    NO  x

The number of shares of the registrant’s Common Stock outstanding as of October 21, 2014 is 29,851,842 shares.

TABLE OF CONTENTS

MAXWELL TECHNOLOGIES, INC.

INDEX TO QUARTERLY REPORT ON FORM 10-Q

For the quarter ended September 30, 2014

		Page
PART I – Financial Information		3
Item 1.	Financial Statements (Unaudited):	3
	Condensed Consolidated Balance Sheets as of September 30, 2014 and December 31, 2013	4
	Condensed Consolidated Statements of Operations – Three and Nine Months Ended September 30, 2014 and 2013	5
	Condensed Consolidated Statements of Comprehensive Income (Loss) – Three and Nine Months Ended September 30, 2014 and 2013	6
	Condensed Consolidated Statements of Cash Flows – Nine Months Ended September 30, 2014 and 2013	7
	Notes to Condensed Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	31
Item 4.	Controls and Procedures	32
PART II – Other Information		33
Item 1.	Legal Proceedings	33
Item 1A.	Risk Factors	33
Item 6.	Exhibits	33
Signatures		34

2

PART I – Financial Information

Item 1. Financial Statements

The following condensed consolidated balance sheet as of December 31, 2013, which has been derived from audited financial statements, and the unaudited interim condensed consolidated financial statements, consisting of the condensed consolidated balance sheet as of September 30, 2014, and the condensed consolidated statements of operations and statements of comprehensive income (loss) for the three and nine months endedSeptember 30, 2014 and 2013, and the condensed consolidated statements of cash flows for the nine months ended September 30, 2014 and 2013, have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading.

The following condensed consolidated balance sheet as of December 31, 2013, which has been derived from audited financial statements, does not include all of the information and footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013. It is suggested that these condensed financial statements be read in conjunction with the financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ materially from those estimates.

In the opinion of management, these unaudited statements contain all adjustments (consisting of normal recurring adjustments, except as otherwise indicated) necessary for a fair presentation for the periods presented as required by Regulation S-X, Rule 10-01.

In addition, operating results for the three and nine months endedSeptember 30, 2014 are not necessarily indicative of the results that may be expected for any subsequent period or for the year ending December 31, 2014.

3

MAXWELL TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except per share data)

(Unaudited)

	September 30, 2014			December 31, 2013
ASSETS
Current assets:
Cash and cash equivalents	$	30,798		$	30,647
Trade and other accounts receivable, net of allowance for doubtful accounts of $107 and $134, at September 30, 2014 and December 31, 2013, respectively	30,636			29,869
Inventories	52,009			44,736
Prepaid expenses and other current assets	2,779			2,314
Total current assets	116,222			107,566
Property and equipment, net	41,018			44,941
Goodwill	24,462			25,978
Pension asset	10,576			10,568
Other non-current assets	878			1,034
Total assets	$	193,156		$	190,087
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities	$	30,696		$	25,616
Accrued employee compensation	10,270			8,788
Deferred revenue and customer deposits	2,826			1,043
Short-term borrowings and current portion of long-term debt	9,280			7,914
Deferred tax liability	813			890
Total current liabilities	53,885			44,251
Deferred tax liability, long-term	2,008			2,125
Long-term debt, excluding current portion	44			100
Other long-term liabilities	3,201			3,401
Total liabilities	59,138			49,877
Commitments and contingencies (Note 9)
Stockholders’ equity:
Common stock, $0.10 par value per share, 40,000 shares authorized; 29,838 and 29,563 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively	2,983			2,953
Additional paid-in capital	276,261			271,928
Accumulated deficit	(155,948		)	(151,794		)
Accumulated other comprehensive income	10,722			17,123
Total stockholders’ equity	134,018			140,210
Total liabilities and stockholders’ equity	$	193,156		$	190,087

See accompanying notes to condensed consolidated financial statements.

4

MAXWELL TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(Unaudited)

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2014			2013		2014			2013
Revenue	$	41,593		$	51,197	$	133,668		$	154,555
Cost of revenue	26,123			30,084		83,728			93,636
Gross profit	15,470			21,113		49,940			60,919
Operating expenses:
Selling, general and administrative	10,823			9,455		32,706			32,945
Research and development	6,923			5,450		19,317			16,851
Total operating expenses	17,746			14,905		52,023			49,796
Income (loss) from operations	(2,276		)	6,208		(2,083		)	11,123
Interest expense, net	49			36		116			121
Amortization of debt discount and prepaid debt costs	5			16		15			46
Income (loss) from operations before income taxes	(2,330		)	6,156		(2,214		)	10,956
Income tax provision	962			129		1,940			1,802
Net income (loss)	$	(3,292	)	$	6,027	$	(4,154	)	$	9,154
Net income (loss) per share:
Basic	$	(0.11	)	$	0.21	$	(0.14	)	$	0.32
Diluted	$	(0.11	)	$	0.21	$	(0.14	)	$	0.32
Weighted average common shares outstanding:
Basic	29,284			28,884		29,146			28,857
Diluted	29,284			28,940		29,146			28,883

See accompanying notes to condensed consolidated financial statements.

5

MAXWELL TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(in thousands)

(Unaudited)

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2014			2013		2014			2013
Net income (loss)	$	(3,292	)	$	6,027	$	(4,154	)	$	9,154
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	(7,119		)	3,778		(6,487		)	1,391
Defined benefit pension plan, net of tax:
Amortization of deferred loss, net of tax benefit of $7 for the three months ended September 30, 2013, net of tax benefit of $21 for the nine months ended September 30, 2013	—			38		—			114
Amortization of prior service cost, net of tax benefit of $7 and $1 for the three months ended September 30, 2014 and 2013, respectively; net of tax benefit of $21 and $7 for the nine months ended September 30, 2014 and 2013, respectively	28			10		86			28
Other comprehensive income (loss), net of tax	(7,091		)	3,826		(6,401		)	1,533
Comprehensive income (loss)	$	(10,383	)	$	9,853	$	(10,555	)	$	10,687

See accompanying notes to condensed consolidated financial statements.

6

MAXWELL TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

	Nine Months Ended
	September 30,
	2014			2013
OPERATING ACTIVITIES:
Net income (loss)	$	(4,154	)	$	9,154
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation	8,267			6,518
Amortization of intangible assets	153			247
Amortization of debt discount and prepaid debt costs	15			46
Pension cost (benefit)	(77		)	15
Stock-based compensation expense	2,934			2,622
Recoveries of losses on accounts receivable	(27		)	(24		)
Provision for losses on inventory	604			1,386
Provision for warranties	594			72
Changes in operating assets and liabilities:
Trade and other accounts receivable	(1,294		)	4,081
Inventories	(8,171		)	(2,247		)
Prepaid expenses and other assets	(538		)	(82		)
Pension asset	(554		)	(649		)
Accounts payable and accrued liabilities	4,906			1,944
Deferred revenue and customer deposits	2,158			(3,814		)
Accrued employee compensation	1,561			3,570
Deferred tax liability, long term	—			(8		)
Other long-term liabilities	(126		)	1,235
Net cash provided by operating activities	6,251			24,066
INVESTING ACTIVITIES:
Purchases of property and equipment	(5,195		)	(11,716		)
Restricted cash	—			(2,300		)
Net cash used in investing activities	(5,195		)	(14,016		)
FINANCING ACTIVITIES:
Principal payments on long-term debt and short-term borrowings	(4,626		)	(7,782		)
Proceeds from long-term and short-term borrowings	6,292			6,475
Repurchase of shares	—			(47		)
Proceeds from issuance of common stock under equity compensation plans	1,430			305
Restricted cash - compensating balance	—			(1,750		)
Net cash provided by (used in) financing activities	3,096			(2,799		)
Increase in cash and cash equivalents from operations	4,152			7,251
Effect of exchange rate changes on cash and cash equivalents	(4,001		)	1,057
Increase in cash and cash equivalents	151			8,308
Cash and cash equivalents, beginning of period	30,647			28,739
Cash and cash equivalents, end of period	$	30,798		$	37,047

See accompanying notes to condensed consolidated financial statements.

7

MAXWELL TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Unless the context otherwise requires, all references to "Maxwell," the "Company," "we," "us," and "our," refer to Maxwell Technologies, Inc. and its subsidiaries; all references to “Maxwell SA” refer to the Company’s Swiss subsidiary, Maxwell Technologies, SA.

Note 1 – Description of Business and Basis of Presentation

Description of Business

Maxwell Technologies, Inc. is a Delaware corporation originally incorporated in 1965 under the name Maxwell Laboratories, Inc. In 1983, the Company completed an initial public offering, and in 1996, changed its name to Maxwell Technologies, Inc. The Company is headquartered in San Diego, California, and has three manufacturing facilities located in San Diego, California; Rossens, Switzerland; and Peoria, Arizona. In addition, the Company has two contract manufacturers located in China. Maxwell operates as one operating segment called High Reliability, which is comprised of three product lines:

• Ultracapacitors: The Company’s primary focus, ultracapacitors, are energy storage devices that possess a unique combination of high power density, extremely long operational life and the ability to charge and discharge very rapidly. The Company’s ultracapacitor cells and multi-cell packs and modules provide highly reliable energy storage and power delivery solutions for applications in multiple industries, including transportation, automotive, information technology, renewable energy and industrial electronics.

• High-Voltage Capacitors: The Company’s CONDIS^® high-voltage capacitors are designed and manufactured to perform reliably for decades in all climates. These products include grading and coupling capacitors and capacitive voltage dividers that are used to ensure the safety and reliability of electric utility infrastructure and other applications involving transport, distribution and measurement of high-voltage electrical energy.

• Radiation-Hardened Microelectronic Products: The Company’s radiation-hardened microelectronic products for satellites and spacecraft include single board computers and components, such as high-density memory and power modules. Many of these products incorporate our proprietary RADPAK^® packaging and shielding technology and novel architectures that enable them to withstand the effects of environmental radiation and perform reliably in space.

The Company’s products are designed to perform reliably for the life of the products and systems into which they are integrated. The Company achieves high reliability through the application of proprietary technologies and rigorously controlled design, development, manufacturing and test processes.

Financial Statement Presentation

The accompanying condensed consolidated financial statements include the accounts of Maxwell Technologies, Inc. and its subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). All intercompany transactions and account balances have been eliminated in consolidation. The Company has prepared the accompanying unaudited interim condensed consolidated financial statements in accordance with the instructions to Form 10-Q and the standards of accounting measurement set forth in the Interim Reporting Topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”). Consequently, the Company has not necessarily included in this Form 10-Q all information and footnotes required for audited financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements in this Form 10-Q contain all adjustments (consisting only of normal recurring adjustments, except as otherwise indicated) necessary to present fairly the financial position, results of operations, and cash flows of Maxwell Technologies, Inc. for all periods presented. The results reported in these condensed consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for any subsequent period or for the entire year. These unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and the notes thereto included in the Company’s latest Annual Report on Form 10-K. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted in the accompanying interim consolidated financial statements. The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.

8

Reclassifications

Certain prior period amounts in the consolidated balance sheets at December 31, 2013 and consolidated statement of cash flows for the nine months ended September 30, 2013 have been reclassified to conform to the current period presentation.These reclassifications do not impact reported net income (loss) and do not otherwise have a material impact on the presentation of the overall financial statements.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts and related disclosures. These estimates include, but are not limited to, assessing the collectability of accounts receivable, applied and unapplied production costs, production capacities, the usage and recoverability of inventories and long-lived assets, including deferred income taxes, the incurrence of warranty obligations, impairment of goodwill and other intangible assets, estimation of the cost to complete certain projects, accruals for estimated losses from legal matters, and estimation of the value of stock-based compensation awards, including the probability that the performance criteria of restricted stock awards will be met.

Valuation Allowance on Deferred Tax Asset

At September 30, 2014, the Company has a cumulative valuation allowance recorded offsetting its worldwide net deferred tax assets of $59.5 million, of which the significant majority represents the valuation allowance on its U.S. net deferred tax asset. The Company has established a valuation allowance against its U.S. federal and state deferred tax assets due to the uncertainty surrounding the realization of such assets. Management periodically evaluates the recoverability of the deferred tax assets and at such time as it is determined that it is more likely than not that U.S. deferred tax assets are realizable, the valuation allowance will be reduced accordingly. Any such release would result in recording a tax benefit that would increase net income in the period the valuation is released.

Warranty Obligation

The Company provides warranties on all product sales. The majority of the Company’s warranties are for one to four years in the normal course of business. The Company accrues for the estimated warranty costs at the time of sale based on historical warranty experience plus any known or expected changes in warranty exposure.

Revenue Recognition

Revenue is derived primarily from the sale of manufactured products directly to customers. Product revenue is recognized, according to the guidelines of the Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin (“SAB”) Numbers 101, Revenue Recognition in Financial Statements, and 104, Revenue Recognition, when all of the following criteria are met: (1) persuasive evidence of an arrangement exists (upon contract signing or receipt of an authorized purchase order from a customer); (2) title passes to the customer at either shipment from the Company’s facilities or receipt at the customer facility, depending on shipping terms; (3) customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collectability is reasonably assured. This policy has been consistently applied from period to period.

Beginning in the fourth quarter of 2011, for three distributors of the Company's products, the Company offered extended payment terms which allowed these distributors to pay the Company after they received payment from their customer, with respect to certain sales transactions. Also beginning in the fourth quarter of 2011, for one other distributor of the Company's products, the Company offered return rights and profit margin protection with respect to certain sales transactions. Therefore, for these four distributors, the Company determined that the revenue recognition criteria of SAB 101 and 104 were not met at the time of shipment, as there was no fixed or determinable price, nor was collection reasonably assured, at least with respect to certain sales transactions. As a result, for the three distributors provided with extended payment terms, which did not provide for a fixed or determinable price, the Company deferred the recognition of revenue on all sales beginning in the fourth quarter of 2011 to the period in which cash is received. For the one distributor provided with return rights and profit margin protection, for which the Company could not estimate exposure, the Company deferred the recognition of revenue on all sales beginning in the fourth quarter of 2011 until the distributor confirmed to the Company that it was not entitled to any further returns or credits. During the third quarter of 2013, this distributor confirmed to the Company that it was not entitled to any further returns or credits, therefore, previously unrecognized revenue related to this distributor was recognized in the quarter ended September 30, 2013. Although the Company had deferred revenue recognition for a significant amount of sales to these four distributors through the quarter ended September 30, 2013, subsequent to this date the amount of deferred revenue related to these distributors has been insignificant.

9

In addition to the deferred revenue arrangements discussed in the preceding paragraph, revenue is not recognized for sales that do not meet the revenue recognition criteria at the time of sale. Revenue is recognized once all of the criteria for revenue recognition are determined to have been met. For example, if the Company does not believe that collection of the sales price is reasonably assured at the time of sale, it defers revenue recognition until cash is received.

As of September 30, 2014 and December 31, 2013, cumulative sales totaling $3.3 million and $4.5 million, respectively, had not yet been recognized as revenue. The Company has recorded the cost basis of inventory shipped to customers prior to the achievement of the revenue recognition criteria of approximately $2.3 million and $2.5 million at September 30, 2014 and December 31, 2013, respectively, in "inventory" in the consolidated balance sheets.

If the Company receives cash payment from the customer prior to the achievement of the revenue recognition criteria, the amount received from the customer is recorded as deferred revenue in the consolidated balance sheets. Total deferred revenue and customer deposits in the consolidated balance sheets as of September 30, 2014 and December 31, 2013 of $2.8 million and $1.0 million, respectively, relates to cash received from customers on sales for which the revenue recognition criteria had not been achieved, customer advances, as well as other less significant customer arrangements requiring the deferral of revenue.

Net Income (Loss) per Share

In accordance with the Earnings Per Share Topic of the FASB ASC, basic net income (loss) per share is calculated using the weighted average number of common shares outstanding during the period. Diluted net income per share includes the impact of additional common shares that would have been outstanding if potentially dilutive common shares were issued. Potentially dilutive securities are not considered in the calculation of diluted net loss per share, as their inclusion would be anti-dilutive. The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share data):

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2014			2013		2014			2013
Numerator
Net income (loss)	$	(3,292	)	$	6,027	$	(4,154	)	$	9,154
Denominator
Weighted-average common shares outstanding	29,284			28,884		29,146			28,857
Effect of potentially dilutive securities:
Options to purchase common stock	—			35		—			17
Restricted stock awards	—			1		—			4
Restricted stock unit awards	—			20		—			5
Weighted-average common shares outstanding, assuming dilution	29,284			28,940		29,146			28,883
Net income (loss) per share
Basic	$	(0.11	)	$	0.21	$	(0.14	)	$	0.32
Diluted	$	(0.11	)	$	0.21	$	(0.14	)	$	0.32

The following table summarizes instruments that may be convertible into common shares that are not included in the denominator used in the diluted net income (loss) per share calculation because to do so would be anti-dilutive (in thousands):

	Three Months Ended		Nine Months Ended
	September 30,		September 30,
	2014	2013	2014	2013
Outstanding options to purchase common stock	701	543	701	743
Unvested restricted stock awards	543	455	543	455
Unvested restricted stock unit awards	168	—	168	13

Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”). The standard provides companies with a single model for accounting for revenue arising from contracts with customers and supersedes current revenue recognition guidance, including industry-specific revenue guidance. The core principle of the model is to recognize revenue when control of the goods or

10

services transfers to the customer, as opposed to recognizing revenue when the risks and rewards transfer to the customer under the existing revenue guidance. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016. Early adoption is not permitted. The guidance permits companies to either apply the requirements retrospectively to all prior periods presented, or apply the requirements in the year of adoption, through a cumulative adjustment.  The Company is in the process of evaluating the impact of adoption on its consolidated financial statements.

In August 2014, the FASB issued ASU No. 2014-15, Disclosure of Uncertainties About an Entity’s Ability to Continue as a Going Concern. The standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued and provides guidance on determining when and how to disclose going concern uncertainties in the financial statements. Certain disclosures will be required if conditions give rise to substantial doubt about an entity’s ability to continue as a going concern. ASU 2014-15 applies to all entities and is effective for annual and interim reporting periods ending after December 15, 2016, with early adoption permitted. The Company does not expect that the adoption of this standard will have a material effect on its financial statements.

Note 2 – Balance Sheet Details (in thousands)

Inventories

	September 30, 2014		December 31, 2013
Raw materials and purchased parts	$	23,966	$	16,723
Work-in-process	2,285		2,374
Finished goods	23,455		23,149
Consigned finished goods	2,303		2,490
Total inventories	$	52,009	$	44,736

Goodwill

The change in the carrying amount of goodwill from December 31, 2013 to September 30, 2014 is as follows:

Balance at December 31, 2013	$	25,978
Foreign currency translation adjustments	(1,516		)
Balance at September 30, 2014	$	24,462

Accumulated Other Comprehensive Income

	Foreign Currency Translation Adjustment			Defined Benefit Pension Plan			Accumulated Other Comprehensive Income			Affected Line Items in the Statement of Operations
Balance as of December 31, 2013	$	18,804		$	(1,681	)	$	17,123
Other comprehensive income before reclassification	(6,487		)	—			(6,487		)
Amounts reclassified from accumulated other comprehensive income	—			86			86			Cost of Sales, Selling, General and Administrative and Research and Development Expense
Net other comprehensive income for the nine months ended September 30, 2014	(6,487		)	86			(6,401		)
Balance as of September 30, 2014	$	12,317		$	(1,595	)	$	10,722

11

Note 3 – Credit Facility

In December 2011, the Company obtained a secured credit facility in the form of a revolving line of credit (the “Revolving Line of Credit”) and an equipment term loan (the “Equipment Term Loan”) (together, the “Credit Facility”). As amended, the Revolving line of Credit was available up to a maximum of $10.0 million. In general, amounts borrowed under the Credit Facility are secured by a lien on all of the Company’s assets other than its intellectual property. In addition, under the credit agreement, as amended, the Company is required to pledge 100% of its equity interests in its Swiss subsidiary. The Company has also agreed not to encumber any of its intellectual property. The agreement contains certain restrictive covenants that limit the Company’s ability to, amongst other things; (i) incur additional indebtedness or guarantees; (ii) create liens or other encumbrances on its property; (iii) enter into a merger or similar transaction; (iv) invest in another entity; (v) declare or pay dividends; and (vi) invest in fixed assets in excess of a defined dollar amount. Repayment of amounts owed pursuant to the Credit Facility may be accelerated in the event that the Company is in violation of any of the representations, warranties and covenants made in the credit agreement, including certain financial covenants. The financial covenants that the Company must meet during the term of the credit agreement, as amended, include quarterly minimum liquidity ratios, minimum cash requirements and net loss targets. Borrowings under the Credit Facility bear interest, payable monthly, at either (i) the bank's prime rate or (ii) LIBOR plus 2.25%, at the Company's option subject to certain limitations. Further, the Company incurs an unused commitment fee, payable quarterly, equal to 0.25% per annum of the average daily unused amount of the Revolving Line of Credit.

The Equipment Term Loan was available to finance 80% of eligible equipment purchases made between April 1, 2011 and April 30, 2012. During this period, the Company borrowed $5.0 million under the Equipment Term Loan. In March 2014, the Company borrowed $3.0 million under the Revolving Line of Credit, and no other amounts have been borrowed to date under the Revolving Line of Credit.

As of December 31, 2013, the Company was not in compliance with the financial covenant pertaining to the quarterly EBITDA target for the quarter ended December 31, 2013. As a result of this noncompliance, borrowings outstanding under the Credit Facility were classified as a current obligation in the consolidated balance sheet as of December 31, 2013.

On August 29, 2014, the Company entered into an amendment to the Credit Facility with the bank where any existing defaults were waived. Under the amendment, the financial covenants that the Company must meet during the term of the credit agreement were revised to include quarterly minimum liquidity ratios, minimum cash requirements and net loss targets.

As of September 30, 2014, the Company was not in compliance with the financial covenant pertaining to the requirement to maintain a quarterly minimum liquidity ratio. As a result of this noncompliance, the bank's obligation to extend any further credit has ceased and terminated and the outstanding debt balance is immediately callable by the bank.

As of September 30, 2014, $1.0 million was outstanding under the Equipment Term Loan and the applicable interest rate was LIBOR plus 2.25% (2.5% as of September 30, 2014). If the bank does not exercise its right to accelerate repayment, under the original terms of the Credit Facility, principal and interest under the Equipment Term Loan are payable in 36 equal monthly installments such that the Equipment Term Loan is fully repaid by the maturity date of April 30, 2015, but may be prepaid in whole or in part at any time. As of September 30, 2014, $3.0 million was outstanding under the Revolving Line of Credit and the applicable interest rate was LIBOR plus 2.25% (2.5% as of September 30, 2014). If the bank does not exercise its right to accelerate repayment, under the amended terms of the Credit Facility, the amount outstanding under the Revolving Line of Credit is scheduled to be repaid by February 28, 2015.

Note 4 – Fair Value Measurements

The Company records certain financial instruments at fair value in accordance with the Fair Value Measurements and Disclosures Topic of the FASB ASC. As of September 30, 2014, the financial instruments to which this topic applied were foreign currency forward contracts. As of September 30, 2014, the fair value of these foreign currency forward contracts was a liability of $1.5 million which is recorded in “accounts payable and accrued liabilities" in the consolidated balance sheet. The fair value of these derivative instruments is measured using models following quoted market prices in active markets for identical instruments, which is a Level 2 input under the fair value hierarchy of the Fair Value Measurements and Disclosures Topic of the FASB ASC. All forward contracts as of September 30, 2014 have approximately a one-month original maturity term and mature on October 2, 2014 or November 4, 2014.

The carrying value of short-term and long-term borrowings approximates fair value because of the relative short maturity of these instruments and the interest rates the Company could currently obtain.

12

Note 5 – Foreign Currency Derivative Instruments

Maxwell uses forward contracts to hedge certain monetary assets and liabilities, primarily receivables and payables, denominated in foreign currencies. The change in fair value of these forward contracts represents a natural hedge as gains and losses on these instruments partially offset the changes in the fair value of the underlying monetary assets and liabilities due to movements in currency exchange rates. These forward contracts generally expire in one month. These contracts are considered economic hedges but are not designated as hedges under the Derivatives and Hedging Topic of the FASB ASC, therefore, the change in the fair value of the instrument is recognized each period in the consolidated statement of operations.

The net gains and losses on foreign currency forward contracts included in cost of revenue and selling, general and administrative expense are as follows (in thousands):

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2014			2013		2014			2013
Cost of revenue	$	2		$	2	$	7		$	32
Selling, general and administrative	(2,717		)	1,377		(3,062		)	(2		)
Total gain (loss)	$	(2,715	)	$	1,379	$	(3,055	)	$	30

The net gains and losses on foreign currency forward contracts were partially offset by net gains and losses on the underlying monetary assets and liabilities. Foreign currency gains and losses on those underlying monetary assets and liabilities included in cost of revenue and selling, general and administrative expense are as follows (in thousands):

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2014			2013			2014			2013
Cost of revenue	$	(12	)	$	(3	)	$	(8	)	$	(28	)
Selling, general and administrative	2,733			(1,545		)	2,513			(503		)
Total gain (loss)	$	2,721		$	(1,548	)	$	2,505		$	(531	)

As of September 30, 2014, the total notional amount of foreign currency forward contracts not designated as hedges was $35.0 million.

The following table presents gross amounts, amounts offset and net amounts presented in the condensed consolidated balance sheets for the Company's derivative instruments measured at fair value (in thousands):

	September 30, 2014			December 31, 2013
Gross amounts of recognized assets (liabilities)	$	(1,668	)	$	472
Gross amounts offset in the condensed consolidated balance sheets	161			(90		)
Net amount of recognized asset (liability) presented in the condensed consolidated balance sheets	$	(1,507	)	$	382

The Company has the legal right to offset these recognized assets and liabilities upon settlement of the derivative instruments. For additional information, refer to Note 4 – Fair Value Measurements.

Note 6 – Stock Plans

The Company has two active stock-based compensation plans as of September 30, 2014: the 2004 Employee Stock Purchase Plan and the 2013 Omnibus Equity Incentive Plan under which incentive stock options, non-qualified stock options, restricted stock awards and restricted stock units can be granted to employees and non-employee directors.

Stock Options

Beginning in 2011, the Company ceased granting stock options to employees as part of its annual equity incentive award program. However, during the three months ended June 30, 2013, the Company granted 75,000 stock options to its former chief operating officer upon his initial engagement with vesting in equal annual installments over four years from the date of grant. Unvested options were cancelled upon his resignation in the third quarter of 2014. The Company may determine to grant stock options in the future to employees as part of its annual equity incentive award program. Compensation expense recognized from employee stock options for the three months ended September 30, 2014 and 2013 was $33,000 and a benefit of $32,000, respectively, and $74,000 and $307,000, respectively, for the nine months ended September 30, 2014 and 2013.

13

Restricted Stock Awards

Beginning in the second quarter of 2014, the Company ceased granting restricted stock awards and began granting restricted stock units to employees as part of its annual equity incentive award program. During the three months ended September 30, 2013, the Company granted 62,500 shares under restricted stock awards which had an average grant date fair value per share of $9.14. During the nine months ended September 30, 2014 and 2013 the Company granted 255,600 and 367,643 shares, respectively, under restricted stock awards, which had an average grant date fair value per share of $14.20 and $10.42, respectively. The following table summarizes the amount of compensation expense recognized for restricted stock awards for the three and nine months endedSeptember 30, 2014 and 2013 (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Service-based restricted stock awards	$	696	$	523	$	1,834	$	1,793
Performance-based restricted stock awards	7		40		20		82
Total compensation expense recognized for restricted stock awards	$	703	$	563	$	1,854	$	1,875

Restricted Stock Units

Non-employee director restricted stock units

Non-employee directors receive an annual restricted stock unit award, normally in February of each year, as part of their annual retainer compensation, which vests one year from the date of grant. Each restricted stock unit represents the right to receive one unrestricted share of the Company’s common stock upon vesting. During the three months ended September 30, 2014 and 2013, no restricted stock units were granted to non-employee directors. During the nine months endedSeptember 30, 2014 and 2013, non-employee directors were granted a total of 65,891 and 69,594 restricted stock units, respectively, with an average grant date fair value per share of $9.03 and $10.25, respectively. Compensation expense recognized for non-employee director restricted stock units for the three months ended September 30, 2014 and 2013 was $146,000 and $188,000, respectively, and $467,000 and $440,000, respectively, for the nine months ended September 30, 2014 and 2013.

Employee restricted stock units

Beginning in the second quarter of 2014, the Company ceased granting restricted stock awards and began granting restricted stock units to employees as part of its annual equity incentive award program. Each restricted stock unit represents the right to receive one unrestricted share of the Company’s common stock upon vesting. During the three months ended September 30, 2014, the Company did not grant any restricted stock units. During the nine months endedSeptember 30, 2014, the Company granted 137,000 restricted stock units to employees of which 67,000 were service-based restricted stock units vesting in equal installments over four years of continuous service with an average grant date value of $15.17 per share, and 70,000 were market-condition restricted stock units vesting upon the achievement of certain stock price thresholds and the completion of three years of continuous employment from the date of grant with an average grant date fair value of $7.71 per share. Since the vesting of the market-condition restricted stock units is dependent on stock price performance, the fair values of these awards were estimated using a Monte-Carlo valuation model with the following weighted-average assumptions:

Market price at grant per share	$	15.03
Expected dividends	$	—
Expected volatility	65		%
Risk-free interest rate	0.86		%
Fair value per unit	$	7.71

14

The following table summarizes the amount of compensation expense recognized for employee restricted stock units for the three and nine months endedSeptember 30, 2014 and 2013 (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Service-based restricted stock units	$	51	$	—	$	83	$	—
Market-condition restricted stock units	34		—		56		—
Total compensation expense recognized for employee restricted stock units	$	85	$	—	$	139	$	—

Employee Stock Purchase Plan

The 2004 Employee Stock Purchase Plan (“ESPP”) permits substantially all employees to purchase common stock through payroll deductions, at 85% of the lower of the trading price of the stock at the beginning or at the end of each six month offering period commencing on January 1 and July 1. The number of shares purchased is based on participants’ contributions made during the offering period.

Compensation expense recognized for the ESPP for the three and nine months ended September 30, 2014 was $57,000 and $400,000, respectively. For the three and nine months ended September 30, 2013, no compensation expense was recognized for the ESPP as the plan had been temporarily suspended. The fair value of the ESPP shares for the three and nine months ended September 30, 2014 was estimated using the Black-Scholes valuation model for a call and a put option with the following weighted-average assumptions:

	Three Months Ended			Nine Months Ended
	September 30,			September 30,
	2014			2014
Expected dividends	$	—		$	—
Exercise price	$	8.72		$	8.09
Expected volatility	61		%	68		%
Risk-free interest rate	0.02		%	0.05		%
Expected life/term (in years)	0.3			0.5
Fair value per share	$	2.37		$	5.89

Stock-Based Compensation Expense

Compensation cost for restricted stock awards, restricted stock units, stock options and the ESPP included in cost of revenue; selling, general and administrative expense; and research and development expense is as follows (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Cost of revenue	$	145	$	228	$	587	$	762
Selling, general and administrative	716		332		1,705		1,337
Research and development	150		159		642		523
Total stock-based compensation expense	$	1,011	$	719	$	2,934	$	2,622

Note 7 – Shelf Registration Statement

On June 3, 2014, the Company filed a shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission ("SEC") to, from time to time, sell up to an aggregate of $125 million of any combination of its common stock, warrants, debt securities or units. On June 30, 2014, the registration statement was declared effective by the SEC, which will allow the Company to access the capital markets for the three year period following this effective date. As of September 30, 2014, no securities have been issued under the Company's shelf registration statement. Net proceeds, terms and pricing of each offering of securities issued under the shelf registration statement will be determined at the time of such offerings.

15

Note 8 – Defined Benefit Plan

Maxwell SA, the Company's Swiss subsidiary, has a retirement plan that is classified as a defined benefit pension plan. The employee pension benefit is based on compensation, length of service and credited investment earnings. The plan guarantees both a minimum rate of return as well as minimum annuity purchase rates. The Company’s funding policy with respect to the pension plan is to contribute the amount required by Swiss law, using the required percentage applied to the employee’s compensation. In addition, participating employees are required to contribute to the pension plan. This plan has a measurement date of December 31.

Components of net periodic pension (benefit) cost are as follows (in thousands):

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2014			2013			2014			2013
Service cost	$	211		$	207		$	645		$	618
Interest cost	174			125			532			374
Expected return on plan assets	(446		)	(383		)	(1,361		)	(1,145		)
Prior service cost amortization	35			11			107			33
Deferred loss amortization	—			45			—			135
Net periodic pension cost (benefit)	$	(26	)	$	5		$	(77	)	$	15

Employer contributions of $182,000 and $178,000 were paid during the three months ended September 30, 2014 and 2013, respectively. Employer contributions of $553,000 and $539,000 were paid during the nine months ended September 30, 2014 and 2013, respectively. Additional employer contributions of approximately $152,000 are expected to be paid during the remainder of fiscal 2014.

Note 9 – Legal Proceedings

Although the Company expects to incur significant legal fees in connection with the below legal proceedings, the Company is unable to estimate the amount of such legal fees and therefore, such fees will be expensed in the period the legal services are performed.

FCPA Matter

As a result of being publicly traded in the U.S., the Company is subject to the U.S. Foreign Corrupt Practices Act (“FCPA”), which prohibits companies from making improper payments to foreign officials for the purpose of obtaining or retaining business. Beginning in 2009, the Company conducted an internal review into payments made to its former independent sales agent in China with respect to sales of its high voltage capacitor products produced by its Swiss subsidiary. In January 2011, the Company reached settlements with the SEC and the U.S. Department of Justice (“DOJ”) with respect to charges asserted by the SEC and DOJ relating to the anti-bribery, books and records, internal controls, and disclosure provisions of the FCPA and other securities laws violations. The Company settled civil charges with the SEC, agreeing to an injunction against further violations of the FCPA. Under the terms of the settlement with the SEC, the Company agreed to pay a total of approximately $6.4 million in profit disgorgement and prejudgment interest. The Company settled civil and criminal charges with the DOJ by entering into a three-year deferred prosecution agreement (“DPA”) and agreeing to pay a total of $8.0 million in penalties. Further, under the terms of each agreement, the Company has submitted periodic reports to the SEC and DOJ on its internal compliance program concerning anti-bribery. As of January 25, 2013, all monetary penalties had been paid in full for each settlement described above and, in early February 2014, the DPA expired on its own terms. A judgment of dismissal was issued by the District Judge for the matter in the U.S. District Court for the Southern District of California on March 28, 2014.

On October 15, 2013, the Company received an informal notice from the DOJ that an indictment against the former Senior Vice President and General Manager of its Swiss subsidiary had been filed in the United States District Court for the Southern District of California. The indictment is against the individual, a former officer, and not against the Company and the Company does not foresee that further penalties or fines could be assessed against it as a corporate entity for this matter. However, the Company may be required throughout the term of the action to advance the legal fees and costs incurred by the individual defendant and to incur other financial obligations. While the Company maintains directors’ and officers’ insurance policies which are intended to cover legal expenses related to its indemnification obligations in situations such as these, the Company cannot determine if and to what extent the insurance policy will cover the legal fees for this matter. Accordingly, the legal fees that may be incurred by the Company in defending this former officer could have a material impact on its financial condition and results of operation.

16

Swiss Bribery Matter

In August 2013, the Company's Swiss subsidiary was served with a search warrant from the Swiss federal prosecutor’s office. At the end of the search, the Swiss federal prosecutor presented the Company with a listing of the materials gathered by the representatives and then removed the materials from its premises for keeping at the prosecutor’s office. By reviewing the items to be seized on the search warrant presented by the Swiss prosecutor’s office, the Company believes this action to be related to the same or similar facts and circumstances as the FCPA action previously settled with the SEC and the DOJ. During initial discussions, the Swiss prosecutor has acknowledged both the existence of the Company's DPA with the DOJ and its cooperation efforts thereunder, both of which should have a positive impact on discussions going forward. Additionally, other than the activities previously reviewed in conjunction with the SEC and DOJ matters under the FCPA, the Company has no reason to believe that additional facts or circumstances are under review by the Swiss authorities. At such an early stage in the investigation, the Company is currently unable to determine the extent to which it will be subject to fines in accordance with Swiss bribery laws and what additional expenses will be incurred in order to defend this matter. As such, the Company cannot determine whether there is a reasonable possibility that a loss will be incurred nor can it estimate the range of any such potential loss. Accordingly, the Company has not accrued an amount for any potential loss associated with this action, but an adverse result could have a material adverse impact on its financial condition and results of operation.

Securities Matter

In early 2013, the Company voluntarily provided information to the United States Attorney's Office for the Southern District of California and the U.S. Securities and Exchange Commission related to its announcement that it intended to file restated financial statements for fiscal years 2011 and 2012. The Company is currently cooperating with the US authorities in connection with these investigations. At this preliminary stage, the Company cannot predict the ultimate outcome of this action, nor can it estimate the range of potential loss. Accordingly, the Company has not accrued an amount for any potential loss associated with this action, but an adverse result could have a material adverse impact on its financial condition and results of operation.

Securities Class Action Matter

From March 13, 2013 through April 19, 2013, four purported shareholder class actions were filed in the United States District Court for the Southern District of California against the Company and certain of its current and former officers. These actions were entitled Foster v. Maxwell Technologies, Inc., et al., Case No. 13-cv-0580 (S.D. Cal. filed March 13, 2013), Weinstein v. Maxwell Technologies, Inc., et al., No. 13-cv-0686 (S.D. Cal. filed March 21, 2013), Abanades v. Maxwell Technologies, Inc., et al., No. 13-cv-0867 (S.D. Cal. filed April 11, 2013), and Mebarak v. Maxwell Technologies, Inc., et al., No. 13-cv-0942 (S.D. Cal. filed April 19, 2013). The complaints alleged that the defendants made false and misleading statements regarding its financial performance and business prospects and overstated the Company's reported revenue. The complaints purported to assert claims for violations of Section 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5 on behalf of all persons who purchased the Company's common stock between April 28, 2011 and March 7, 2013, inclusive. The complaints sought unspecified monetary damages and attorneys' fees and costs. On May 13, 2013, four prospective lead plaintiffs filed motions to consolidate the four actions and to be appointed lead plaintiff and, on October 24, 2013, the court issued a written order consolidating the case under the heading In re Maxwell Technologies, Inc., Securities Litigation. On January 16, 2014, the lead plaintiff filed a consolidated and amended complaint which slightly adjusted the class period to April 29, 2011 to March 19, 2013. In response, the Company and the individual defendants filed a motion to dismiss the complaint, which the lead plaintiff opposed. On May 5, 2014, the court granted the Company’s motion to dismiss but granted the lead plaintiff leave to amend its complaint. The lead plaintiff filed an amended complaint on June 4, 2014, and the Company and individual defendants filed motions to dismiss on July 10, 2014. On October 6, 2014, the parties executed a stipulation of settlement, which included an all-in settlement value of $3.3 million. On October 16, 2014, the lead plaintiff filed a motion for preliminary approval of the settlement. As a result of the preliminary settlement, for the quarter ended September 30, 2014, the Company accrued a liability of $3.3 million, which is included in “accounts payable and accrued liabilities,” and a corresponding receivable of $3.3 million, which is included in “trade and other accounts receivable,” as this amount is payable by the Company's insurance carrier.

17

Federal Shareholder Derivative Matter

On April 23, 2013 and May 7, 2013, two shareholder derivative actions were filed in the United States District Court for the Southern District of California, entitled Kienzle v. Schramm, et al., Case No. 13-cv-0966 (S.D. Cal. filed April 23, 2013) and Agrawal v. Cortes, et al., Case No. 13-cv-1084 (S.D. Cal. filed May 7, 2013). The complaints name as defendants certain of the Company's current and former officers and directors and names the Company as a nominal defendant. The complaints allege that the individual defendants caused or allowed the Company to issue false and misleading statements about its financial condition, operations, management, and internal controls and falsely represented that it maintained adequate controls. The complaints assert causes of action for breach of fiduciary duty, abuse of control, gross mismanagement, waste of corporate assets and unjust enrichment. The lawsuits seek unspecified damages, an order directing the Company to take all necessary actions to reform and improve its corporate governance and internal procedures, restitution and disgorgement of profits, benefits, and other compensation, attorneys' and experts' fees, and costs and expenses. On June 10, 2013, the parties filed a joint motion to consolidate the two actions. On September 26, 2013, the plaintiffs filed a motion to stay this case until the resolution of the similar derivative action pending in the California Superior Court for the County of San Diego. The Company and individual defendants opposed this motion to stay. On October 30, 2013, the court issued two orders consolidating the two cases under the heading In re Maxwell Technologies, Inc. Derivative Litigation, which had been mutually agreed upon by all parties, and denying the plaintiffs’ motion to stay their own federal derivative case. The lead plaintiffs filed their consolidated and amended complaint on January 30, 2014. In response, the Company and the individual defendants filed motions to dismiss the complaint, which the lead plaintiffs opposed. On May 28, 2014, the court granted the Company’s motion to dismiss but granted the lead plaintiffs leave to amend their complaint. The lead plaintiffs filed an amended complaint on July 11, 2014, to which the Company and individual defendants filed motions to dismiss on August 18, 2014. On September 19, 2014, the parties entered a memorandum of understanding concerning settlement of this matter with respect to certain corporate governance reforms to be implemented and/or maintained by the Company. This memorandum of understanding does not address any monetary amounts to be paid to the lead plaintiffs in exchange for the benefit conferred to the Company as a result of the corporate governance reforms. Negotiations have been initiated with respect to the monetary amounts to be paid to lead plaintiffs and such preliminary amounts have been in the range of $650,000 to $1.5 million. As the Company believes that settlement within this range is probable, but does not believe that a specific amount within this range represents a better estimate, the Company accrued a liability for the low end of this range in the amount of $650,000, which is included in “accounts payable and accrued liabilities” for the quarter ended September 30, 2014. As the Company’s insurance carrier would cover this potential settlement, the Company recorded a corresponding receivable from the insurance carrier in the amount of $650,000, which is included in “trade and other accounts receivable,” for the quarter ended September 30, 3014. Pursuant to the status report that the parties submitted to the court on October 6, 2014, the lead plaintiffs will file a motion for preliminary approval of the settlement on or before November 14, 2014.

State Shareholder Derivative Matter

On April 11, 2013 and April 18, 2013, two shareholder derivative actions were filed in California Superior Court for the County of San Diego, entitled Warsh v. Schramm, et al., Case No. 37-2013-00043884 (San Diego Sup. Ct. filed April 11, 2013) and Neville v. Cortes, et al., Case No. 37-2013-00044911-CU-BT-CTL (San Diego Sup. Ct. filed April 18, 2013). The complaints name as defendants certain of the Company's current and former officers and directors as well as its former auditor McGladrey LLP. The Company is named as a nominal defendant. The complaints allege that the individual defendants made or caused the Company to make false and/or misleading statements regarding its financial condition, and failed to disclose material adverse facts about its business, operations and prospects. The complaints assert causes of action for breaches of fiduciary duty for disseminating false and misleading information, failing to maintain internal controls, and failing to properly oversee and manage the Company, as well as for unjust enrichment, abuse of control, gross mismanagement, professional negligence and accounting malpractice, and aiding and abetting breaches of fiduciary duty. The lawsuits seek unspecified damages, an order directing the Company to take all necessary actions to reform and improve its corporate governance and internal procedures, restitution and disgorgement of profits, benefits and other compensation, attorneys' and experts' fees, and costs and expenses. On May 7, 2013, the court consolidated the two actions. The Company filed a motion to stay the consolidated action on July 2, 2013. On September 27, 2013, the court heard oral arguments on the motion to stay and continued the hearing on this motion until the resolution of the motion to stay pending in the federal derivative action referenced above. Given the outcome of the above-detailed federal derivative lawsuit, the Company informed the state court of the federal court order denying the federal plaintiffs’ motion to stay. Consequently, on November 1, 2013, the state court stayed the state derivative action pending before it until the resolution of the federal derivative case. The memorandum of understanding concerning settlement in the federal shareholder derivative matter contemplates that this action will be dismissed with prejudice in the event that settlement is approved by the federal court.

18

Shareholder Demand Letter Matter

On April 9, 2013, Stephen Neville, a purported shareholder of the Company, sent a demand letter to the Company to inspect its books and records pursuant to California Corporations Code Section 1601. The demand sought inspection of documents related to the Company's March 7, 2013 announcement that it would be restating its previously-issued financial statements for 2011 and 2012, board minutes and committee materials, and other documents related to its board or management discussions regarding revenue recognition from January 1, 2011 to the present. The Company responded by letter dated April 19, 2013, explaining why it believed that the demand did not appear to be proper. Following receipt of a second letter from Mr. Neville dated April 23, 2013, the Company explained by letter dated April 29, 2013 why it continues to believe that the inspection demand appears improper. The Company has not received a further response from Mr. Neville regarding the inspection demand. In conjunction with the state Court derivative action referenced above, Mr. Neville filed two motions to compel production of the documents and materials originally sought in the demand letter. On September 27, 2013, the Court heard oral arguments on the motions to compel and, in line with the continuance on the motion to stay in the state shareholder derivative matter referenced above, likewise continued the hearing on the motions to compel, pending resolution of the motions to stay in both the federal and state derivative actions referenced above. On November 15, 2013, the purported shareholder, Mr. Neville, filed a petition for writ of mandate requesting that the state Court order the Company to comply with the inspection demand. The Company responded to this writ on January 15, 2014, claiming that the inspection demand is improper on numerous grounds and simultaneously filing a demurrer to the shareholder inspection demand action in its entirety. On July 18, 2014, the Court ruled against the Company’s demurrer but left open issues pertaining to the documents to be provided, if any, under the purported shareholder inspection demand. The Court set a further hearing in this matter for April 10, 2015. The memorandum of understanding concerning settlement in the federal shareholder derivative matter contemplates that this action will be dismissed with prejudice in the event that settlement is approved by the federal Court.

19

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Unless the context otherwise requires, all references to “Maxwell,” “the Company,” “we,” “us,” and “our” refer to Maxwell Technologies, Inc. and its subsidiaries. All references to “Maxwell SA” refer to our Swiss subsidiary, Maxwell Technologies, SA.

FORWARD-LOOKING STATEMENTS

Some of the statements contained in this document and incorporated herein by reference discuss our plans and strategies for our business or make other forward-looking statements, as this term is defined in the Private Securities Litigation Reform Act. The words “anticipates,” “believes,” “estimates,” “expects,” “plans,” “intends,” “may,” “could,” “will,” “continue,” “seek,” “should,” “would” and similar expressions are intended to identify these forward-looking statements, but are not the exclusive means of identifying them. These forward-looking statements reflect the current views and beliefs of our management; however, various risks, uncertainties and contingencies could cause our actual results, performance or achievements to differ materially from those expressed in, or implied by, our statements. Such risks, uncertainties and contingencies include, but are not limited to, the following:

• our ability to remain competitive and stimulate customer demand through successful introduction of new products, and to educate our prospective customers on the products we offer;

• dependence upon the sale of products to a small number of customers and vertical markets, some of which are heavily dependent on government funding or government subsidies which may or may not continue in the future;

• dependence upon the sale of products into Asia and Europe, where macroeconomic factors outside our control may adversely affect our sales;

• risks related to our international operations including, but not limited to, our ability to adequately comply with the changing rules and regulations in countries where our business is conducted, our ability to oversee and control our foreign subsidiaries and their operations, our ability to effectively manage foreign currency exchange rate fluctuations arising from our international operations, and our ability to continue to comply with the U.S. Foreign Corrupt Practices Act as well as the anti-bribery laws of foreign jurisdictions;

• successful acquisition, development and retention of key personnel;

• our ability to effectively manage our reliance upon certain suppliers of key component parts, specialty equipment and logistical services;

• our ability to match production volume to actual customer demand;

• our ability to manage product quality problems;

• our ability to protect our intellectual property rights and to defend claims against us;

• our ability to effectively identify, enter into, manage and benefit from strategic alliances;

• occurrence of a catastrophic event at any of our facilities;

• occurrence of a technology systems failure, network disruption, or breach in data security;

• our ability to obtain sufficient capital to meet our operating or other needs; and,

• our ability to manage and minimize the impact of unfavorable legal proceedings.

Many of these factors are beyond our control. Additionally, there can be no assurance that we will not incur new or additional unforeseen costs in connection with the ongoing conduct of our business. Accordingly, any forward-looking statements included herein do not purport to be predictions of future events or circumstances and may not be realized.

For a discussion of important risks associated with an investment in our securities, including factors that could cause actual results to differ materially from expectations referred to in the forward-looking statements, see Risk Factors in Part II, Item 1A, of this document and Part I, Item 1A, of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013. We do not have any obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

20

Overview

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is designed to provide a reader of our financial statements with a narrative from the perspective of our management on our financial condition, results of operations, liquidity and certain other factors that may affect our future results. Our MD&A is presented in the following sections:

• Executive Overview

• Highlights of the Nine Months Ended September 30, 2014

• Results of Operations

• Liquidity and Capital Resources

• Critical Accounting Policies and Estimates

• Off Balance Sheet Arrangements

Executive Overview

Maxwell is a global leader in developing, manufacturing and marketing energy storage and power delivery products for transportation, industrial, information technology and other applications and microelectronic products for space and satellite applications. Our products are designed and manufactured to perform reliably with minimal maintenance for the life of the applications into which they are integrated. We believe that this “life-of-the-application” reliability gives our products a competitive advantage and enables them to command higher profit margins than commodity products. We have three product lines: ultracapacitors with applications in multiple industries, including transportation, automotive, information technology, renewable energy and consumer and industrial electronics; high-voltage capacitors applied mainly in electrical utility infrastructure; and radiation-hardened microelectronic products for space and satellite applications.

Our primary objective is to grow revenue and profit margins by creating and satisfying demand for ultracapacitor-based energy storage and power delivery solutions. We are focusing on establishing and expanding market opportunities for ultracapacitors and being the preferred supplier for ultracapacitor products worldwide. We believe that the transportation industry represents the largest market opportunity for ultracapacitors, primarily for applications related to engine starting, electrical system augmentation, and braking energy recuperation and hybrid electric drive systems for transit buses, trucks and autos, and electric rail vehicles. Backup power and power quality applications, including instantly available power for uninterruptible power supply systems, and stabilizing the output of renewable energy generation systems may also represent significant market opportunities.

We also seek to expand market opportunities and revenue for our high-voltage capacitors and radiation-hardened microelectronic products. The market for high-voltage capacitors consists mainly of expansion, upgrading and maintenance of existing electrical utility infrastructure and new infrastructure installations in developing countries. Such installations are capital-intensive and frequently are subject to regulation, availability of government funding and general economic conditions. Although the market for microelectronics products for space and satellite applications is relatively small, the specialized nature of these products and the requirement for failure-free reliability allows us to generate profit margins significantly higher than those for commodity electronic components.

In the third quarter of 2014, revenues were $41.6 million, representing a decrease of 19% compared with $51.2 million in the same period one year ago. The decrease is primarily attributable to lower revenue for our ultracapacitor products, for which revenue decreased by 22% to $28.8 million in the third quarter of 2014 from $37.0 million in the third quarter of 2013. The higher ultracapacitor revenues for the third quarter of 2013 were attributable to the recognition of $11.3 million in previously deferred ultracapacitor revenue, net of revenues deferred in the period. Excluding this impact, sales of our ultracapacitor products into the rail transit, automotive and heavy transportation markets increased significantly in the third quarter of 2014 compared with the third quarter of 2013, offset by a decline in sales into the hybrid transit vehicle market compared with same period one year ago.

Revenues for our high voltage capacitor products increased by $722,000 to $10.4 million for the third quarter of 2014 compared with $9.7 million for the same period in the prior year. Revenues for our microelectronics products declined to $2.4 million for the third quarter of 2014 compared with $4.5 million for the same period in 2013. Microelectronics revenues were higher than typical for the third quarter of 2013 due to certain large sales associated with one-time programs, and have also trended down in recent quarters due to softening demand. Overall gross profit margin during the quarter decreased to 37% compared with 41% in the third quarter of 2013, primarily due to lower production volume as well as higher production costs associated with the opening of our new manufacturing facility in Peoria, Arizona. Operating expenses in the third quarter of 2014 increased to 43% of revenue, compared with 29% of revenue in the same period one year ago, associated with both the decline in revenues as well as a 19% increase in operating expenses in absolute dollars.

21

As of September 30, 2014, we had cash and cash equivalents of $30.8 million. Management believes that this available cash balance, combined with cash we expect to generate from operations, will be sufficient to fund our operations, obligations as they become due, and capital investments for at least the next twelve months. In the future, we may decide to supplement existing cash and planned cash flow from operations by borrowing additional funds or by issuing additional debt or equity.

Going forward, we will continue to focus on growing our business and strengthening our market leadership and brand recognition through further penetration of existing markets, entry into new markets and development of new products. Our primary focus will be to grow our ultracapacitor business by increasing sales into primary applications, including automotive, transportation, renewable energy and backup power. In order to achieve our growth objectives, we will need to overcome risks and challenges facing our business.

A significant challenge we face is our ability to manage dependence on a small number of vertical markets, including some that are driven by government policies and subsidy programs. For example, a large portion of our current ultracapacitor business is concentrated in the Chinese hybrid transit bus and wind energy markets, which are heavily dependent on government regulation and subsidy. These markets may decline or experience slower rates of growth when there are changes or delays in government policies and subsidy programs. In mid-2013, the Chinese government subsidy program for diesel-electric hybrid buses concluded, and has not been renewed. However, our Chinese bus customers are now receiving significant orders for subsidized plug-in hybrid buses that incorporate ultracapacitor content similar to that for diesel-electric hybrid buses. We are focused on supporting this plug-in hybrid demand, which we expect to continue to contribute to sales of our ultracapacitor products. The current subsidy program is scheduled to expire at the end of 2015, although it may be renewed or replaced.

Although we believe the long-term prospects for the automotive, wind and hybrid bus markets remain positive, we are pursuing growth opportunities for our products in other vertical markets, including applications for back-up power, power quality and heavy vehicle engine starting in order to further diversify our market presence and augment our long-term growth prospects.

Other significant risks and challenges we face include the ability to achieve profitability; the ability to develop our management team, product development infrastructure and manufacturing capacity to facilitate growth; competing technologies that may capture market share and interfere with our planned growth; and hiring, developing and retaining key personnel critical to the execution of our strategy. We will be attentive to these risks and will focus on developing new products and promoting the value proposition of our products versus competing technologies and trying to grow our revenues and profits in the years to come.

Highlights of Nine Months Ended September 30, 2014

During the nine months ended September 30, 2014, we continued to focus on introducing new products, winning new customers, new product applications, increasing production capacity to meet anticipated future demand, reducing product costs, making capital investments to facilitate growth, and improving production processes. Some of these efforts are described below:

• In February, we announced that we supplied seven powerful single board computers that are providing processing power for the European Space Agency's Gaia Satellite, which lifted off on December 19, 2013.

• Also in February, we announced that we are supplying ultracapacitor-based Engine Start Modules to Idle Free Systems, Inc., a leader in anti-idling solutions for the trucking industry, to provide cranking power for a new anti-idling system into vocational markets across North America.

• In March, we introduced our ultracapacitor-based Engine Start Module for medium duty diesel trucks. Consistent with the current Engine Start Module, the new product provides the same benefits to class 3 through 6 medium duty trucks.

• In April, we announced that we are supplying ultracapacitors to ABB, the global leader in power and automation solutions. ABB will incorporate Maxwell ultracapacitors in a new hybrid version of its high-efficiency energy recovery and storage system for the light rail system serving the greater Philadelphia area.

• In June, we introduced our new 2.85 volt, 3400-farad ultracapacitor cell which incorporates our DuraBlue Shock and Vibration Technology, and is our newest innovation in ultracapacitor reliability and performance.

• In August,we introduced our new Electronic Voltage Transformer (EVT) for smart grid applications. Our EVT provides Integrators and Utilities with a smaller, lower-weight solution for compact substations and provides more accurate grid measurement.

• Also in August, we announced that Win Inertia, an engineering firm specializing in power electronics, energy storage and control and communication systems, is using our ultracapacitors for a stationary wayside braking energy recuperation system at an electric rail system in Cerro Negro, Spain.

22

• In October, we announced that we had won an Energy Storage North America (ESNA) Innovation Award, which honors energy storage projects in North America that help solve the challenge of creating a stable and dynamic electricity grid. Maxwell's project to provide ultracapacitors to ABB, the global leader in power and automation solutions, allows Philadelphia-area rail lines to be more energy efficient. The project earned the ESNA Innovation Award in the mobility project category.

23

Results of Operations

The Three Months Ended September 30, 2014 Compared with the Three Months Ended September 30, 2013

The following table presents certain unaudited statement of operations data expressed as a percentage of revenue for the periods indicated:

	Quarter Ended
	September 30,
	2014		2013
Revenue	100	%	100	%
Cost of revenue	63	%	59	%
Gross profit	37	%	41	%
Operating expenses:
Selling, general and administrative	26	%	18	%
Research and development	17	%	11	%
Total operating expenses	43	%	29	%
Income (loss) from operations	(6	)%	12	%
Interest expense, net	—	%	—	%
Income (loss) from operations before income taxes	(6	)%	12	%
Income tax provision	2	%	—	%
Net income (loss)	(8	)%	12	%

Net loss reported for the three months ended September 30, 2014 was $3.3 million, or $0.11 per share, compared with net income of $6.0 million, or $0.21 per diluted share, in the same quarter one year ago. This decrease was primarily driven by a decrease in revenue of 19% to $41.6 million for the three months ended September 30, 2014 compared with $51.2 million for the same period of the prior year, and a decline in gross profit as a percent of revenue to 37%, compared with 41% in the same quarter of the prior year. Additionally, operating expenses increased 19% to $17.7 million for the three months ended September 30, 2014 from $14.9 million in the same period of the prior year, primarily associated with headcount growth for sales and marketing and research and development.

Revenue and Gross Profit

The following table presents a comparison of revenue, cost of revenue and gross profit for the quarters ended September 30, 2014 and 2013 (in thousands, except percentages):

	Quarter Ended				Quarter Ended
	September 30, 2014				September 30, 2013
	Amount		% of Revenue		Amount		% of Revenue		Decrease			% Change
Revenue	$	41,593	100	%	$	51,197	100	%	$	(9,604	)	(19	)%
Cost of revenue	26,123		63	%	30,084		59	%	(3,961		)	(13	)%
Gross profit	$	15,470	37	%	$	21,113	41	%	$	(5,643	)	(27	)%

Revenue. In the third quarter of 2014, revenue decreased 19% to $41.6 million, compared with $51.2 million in the same quarter one year ago. The decrease in revenue was influenced primarily by lower revenues for our ultracapacitor product line which decreased by 22% to $28.8 million in the third quarter of 2014 from $37.0 million in the third quarter of 2013. This decline in revenues for our ultracapacitor products is primarily attributable to the recognition of $11.3 million in previously deferred ultracapacitor revenue, net of revenues deferred in the period, in the third quarter of 2013. Excluding this impact, sales of our ultracapacitor products into the rail transit, automotive and heavy transportation markets increased significantly in the third quarter of 2014 compared with the third quarter of 2013, offset by a decline in sales into the hybrid transit vehicle market compared with same period one year ago.

Revenues for our high voltage products increased by $722,000 to $10.4 million for the third quarter of 2014, compared with $9.7 million in the same quarter one year ago. Revenues for our microelectronics products decreased by $2.2 million with total revenues of $2.4 million in the third quarter of 2014 compared with total revenues of $4.5 million for the third quarter of 2013. Microelectronics revenues were higher for the third quarter of 2013 than typical due to certain large sales associated with one-time programs, and have also trended down in recent quarters due to softening demand.

24

Gross Profit. In the third quarter of 2014, gross profit decreased $5.6 million or 27% to $15.5 million compared with $21.1 million in the third quarter of 2013. Of the decrease in gross profit in absolute dollars, $3.7 million related to a decrease in sales and $1.9 million related to an increase in product costs, primarily associated with the opening of our new manufacturing facility in Peoria, Arizona, as well as unabsorbed overhead costs related to the lower volume.

As a percentage of revenue, gross profit margin decreased to 37% in the third quarter of 2014 compared with 41% in the same quarter one year ago. This decrease in gross profit as a percentage of revenue was primarily related to higher per unit costs associated with lower production volume and higher production costs associated with our new manufacturing facility, as noted above.

Selling, General and Administrative Expense

The following table presents selling, general and administrative expense for the third quarter of 2014 and 2013 (in thousands, except percentages):

	Quarter Ended				Quarter Ended
	September 30, 2014				September 30, 2013
	Amount		% of Revenue		Amount		% of Revenue		Increase		% Change
Selling, general and administrative	$	10,823	26	%	$	9,455	18	%	$	1,368	14	%

Selling, general and administrative expenses were 26% of revenue for the third quarter of 2014, up from 18% in the same quarter in 2013, while total expenses increased by $1.4 million, or 14%. The increase in absolute dollars was primarily attributable to an increase in labor expenses of $1.7 million in the third quarter of 2014 compared with the same quarter one year ago. These costs included an increase of $894,000 related to additional headcount for sales and marketing and an increase in general and administrative compensation costs of $815,000 related to increased headcount and severance compensation for our departing chief operating officer. In addition, travel expenses increased by $273,000 for the third quarter of 2014, mainly related to increased customer relations and sales efforts. Offsetting this impact, legal, audit, tax and related consulting fees decreased by $622,000 in the third quarter of 2014, mainly related to the audit committee's investigation, our internal review and the restatement of previously issued financial statements in the third quarter of 2013. Selling, general and administrative expenses increased to 26% of revenue for the third quarter of 2014, up from 18% for the same quarter in 2013, resulting from both the increased expenses and decrease in revenues for the third quarter of 2014.

Research and Development Expense

The following table presents research and development expense for the third quarter of 2014 and 2013 (in thousands, except percentages):

	Quarter Ended				Quarter Ended
	September 30, 2014				September 30, 2013
	Amount		% of Revenue		Amount		% of Revenue		Increase		% Change
Research and development	$	6,923	17	%	$	5,450	11	%	$	1,473	27	%

Research and development expenses were 17% of revenue for the third quarter of 2014, up from 11% in the same quarter in 2013, while total expenses increased by $1.5 million. The increase in absolute dollars was primarily driven by an increase of $838,000 in labor expenses related to increased headcount to support efforts to improve manufacturing processes and to develop and enhance products. In addition, there was an increase of $478,000 in outsourced research and development services and materials consumption to support specific research programs to discover new technology and develop existing technology. In addition to the increase in absolute dollars, research and development expenses increased to 17% of revenue for the third quarter of 2014, up from 11% for the same quarter in 2013, as both expenses were higher and revenues were lower for the third quarter of 2014.

Provision for Income Taxes

The effective tax rate differs from the statutory U.S. federal income tax rate of 34% primarily due to foreign income tax and the valuation allowance against the Company’s domestic deferred tax assets.

We recorded an income tax provision of $962,000 for the third quarter of 2014 compared with $129,000 for the same quarter in 2013. This provision is primarily related to taxes on income generated by our Swiss subsidiary. The increase in the income tax provision for the third quarter of 2014 is primarily a result of higher Swiss income due to an increase in foreign exchange gains in the third quarter of 2014, as well as a $258,000 benefit recorded in the third quarter of 2013 related to the

25

release of a tax reserve upon the expiration of a statute of limitations. Unremitted earnings of foreign subsidiaries have been included in the consolidated financial statements without giving effect to the United States taxes that may be payable as it is not anticipated such earnings will be remitted to the United States. The Company has established a valuation allowance against its U.S. federal and state deferred tax assets, as well as the deferred tax asset of a foreign subsidiary, due to the uncertainty surrounding the realization of such assets as evidenced by the cumulative losses from operations through September 30, 2014. Management periodically evaluates the recoverability of the deferred tax assets and at such time as it is determined that it is more likely than not that deferred assets are realizable, the valuation allowance will be reduced accordingly.

At September 30, 2014, we have a cumulative valuation allowance recorded offsetting our worldwide net deferred tax assets of $59.5 million, of which the significant majority represents the valuation allowance on our U.S. net deferred tax asset. We have established a valuation allowance against our U.S. federal and state deferred tax assets due to the uncertainty surrounding the realization of such assets. Management periodically evaluates the recoverability of the deferred tax assets and at such time as it is determined that it is more likely than not that U.S. deferred tax assets are realizable, the valuation allowance will be reduced accordingly.

The Nine Months Ended September 30, 2014 Compared with the Nine Months Ended September 30, 2013

The following table presents certain unaudited statement of operations data expressed as a percentage of revenue for the periods indicated:

	Nine Months Ended
	September 30,
	2014		2013
Revenue	100	%	100	%
Cost of revenue	63	%	61	%
Gross profit	37	%	39	%
Operating expenses:
Selling, general and administrative	24	%	21	%
Research and development	14	%	11	%
Total operating expenses	38	%	32	%
Income (loss) from operations	(1	)%	7	%
Interest expense, net	1	%	—	%
Income (loss) from operations before income taxes	(2	)%	7	%
Income tax provision	1	%	1	%
Net income (loss)	(3	)%	6	%

Net loss reported for nine months endedSeptember 30, 2014 was $4.2 million, or $0.14 per share, compared with net income of $9.2 million, or $0.32 per diluted share, in the same period one year ago. This decrease was primarily driven by a decrease in revenue of 14% to $133.7 million for nine months endedSeptember 30, 2014 compared with revenue of $154.6 million in the same period of the prior year, and a decline in gross profit as a percent of revenue to 37%, compared with 39% in the same nine months of the prior year. Operating expenses increased 4% to $52.0 million for the nine months endedSeptember 30, 2014 from $49.8 million in the same period of the prior year, primarily associated with headcount growth for sales and marketing and research and development.

Revenue and Gross Profit

The following table presents a comparison of revenue, cost of revenue and gross profit for nine months endedSeptember 30, 2014 and 2013 (in thousands, except percentages):

	Nine Months Ended				Nine Months Ended
	September 30, 2014				September 30, 2013
	Amount		% of Revenue		Amount		% of Revenue		Decrease			% Change
Revenue	$	133,668	100	%	$	154,555	100	%	$	(20,887	)	(14	)%
Cost of revenue	83,728		63	%	93,636		61	%	(9,908		)	(11	)%
Gross profit	$	49,940	37	%	$	60,919	39	%	$	(10,979	)	(18	)%

26

Revenue. In the nine months endedSeptember 30, 2014, revenue decreased 14% to $133.7 million, compared with $154.6 million in the same period one year ago. The decrease in revenue was influenced primarily by lower revenues for our ultracapacitor product line which decreased by 14% to $94.7 million in the first nine months of 2014 from $110.0 million in the same period in the prior year. This decline in revenues for our ultracapacitor products is primarily attributable to the recognition of $11.5 million in previously deferred ultracapacitor revenue, net of revenues deferred in the period, in the first nine months of 2013. This decline in revenue is also associated with reduced ultracapacitor sales in the Chinese hybrid transit vehicle market primarily related to the expiration of a Chinese government subsidy program for diesel-electric hybrid buses in the middle of 2013, which was replaced with a subsidy program for plug-in hybrid buses. Under the new subsidy program, plug-in hybrid bus manufacturers are incorporating our ultracapacitor products, for which demand has been lower to date than under the previous subsidy program for diesel-electric hybrid buses. This decline in revenues for the hybrid transit vehicle market was partially offset by increased revenues for the rail transit, wind energy, and automotive markets.

Revenues for our high voltage products decreased by $3.8 million to $30.5 million for the first nine months of 2014, compared with $34.3 million in the same period one year ago as we are currently experiencing reduced global demand for these products. Revenues for our microelectronics products, decreased by $1.8 million with total revenues of $8.4 million in the first nine months of 2014 compared with total revenues of $10.2 million for the first nine months of 2013. Microelectronics revenues were higher for the third quarter of 2013 than typical due to certain large sales associated with one-time programs, and have also trended down in recent quarters due to softening demand.

A substantial amount of our revenue is generated through our Swiss subsidiary which has a functional currency of the Swiss Franc. As such, reported revenue can be materially impacted by the changes in exchange rates between the Swiss Franc and the U.S. Dollar, our reporting currency. Due to the weakening of the U.S. Dollar against the Swiss Franc during the nine months endedSeptember 30, 2014 compared with the same period one year ago, revenue was positively impacted by $1.0 million.

Gross Profit. In the first nine months of 2014, gross profit decreased $11.0 million to $49.9 million compared with $60.9 million the first nine months of 2013. Of the decrease in gross profit in absolute dollars, $8.1 million related to a decrease in sales, and $2.8 million related to an increase in product costs, primarily associated with the opening of our new manufacturing facility in Peoria, Arizona, as well as provisions taken for certain excess or obsolete inventory items.

As a percentage of revenue, gross profit margin decreased to 37% for the first nine months of 2014 compared with 39% in the same period one year ago. This decrease in gross profit as a percentage of revenue was primarily related to higher per unit costs associated with lower production volume and higher production costs associated with our new manufacturing facility, as noted above.

Selling, General and Administrative Expense

The following table presents selling, general and administrative expense for first nine months of 2014 and 2013 (in thousands, except percentages):

	Nine Months Ended				Nine Months Ended
	September 30, 2014				September 30, 2013
	Amount		% of Revenue		Amount		% of Revenue		Decrease			% Change
Selling, general and administrative	$	32,706	24	%	$	32,945	21	%	$	(239	)	(1	)%

Selling, general and administrative expenses were 24% of revenue for the first nine months of 2014, up from 21% in the same period one year ago, while total expenses decreased by $239,000, or 1%. Legal, audit, tax and consulting fees were higher by $4.9 million in the first nine months of 2013, mainly related to the audit committee's investigation, our internal review and the restatement of previously issued financial statements. This impact was offset by an increase in labor expenses of $2.5 million in the first nine months of 2014 compared with 2013, of which $2.1 million related to additional headcount for sales and marketing and $411,000 related to equity grants for our new chief executive officer and severance payments for our departing chief operating officer. Additionally, recruiting expenses increased by $386,000 primarily due to the search for our new chief executive officer and additional staff for our San Diego and Asia facilities. In addition, travel expenses increased by $559,000 mainly related to customer relations and sales efforts, and information technology and facilities expenses increased by a total of $251,000 in support of the increase in headcount. Further, advertising and promotion expenses increased by $320,000, mainly related to an increased focus on advertising for our newer engine starting product. Despite the decline in absolute dollars, selling, general and administrative expenses increased to 24% of revenue for the first nine months of 2014, up from 21% for the same period in 2013, as a result of the lower revenues for the first nine months of 2014.

27

Research and Development Expense

The following table presents research and development expense for the first nine months of 2014 and 2013 (in thousands, except percentages):

	Nine Months Ended				Nine Months Ended
	September 30, 2014				September 30, 2013
	Amount		% of Revenue		Amount		% of Revenue		Increase		% Change
Research and development	$	19,317	14	%	$	16,851	11	%	$	2,466	15	%

Research and development expenses were 14% of revenue for the first nine months of 2014, up from 11% in the same period one year ago, while total expenses increased by $2.5 million, or 15%. The increase in absolute dollars was primarily driven by an increase of $1.5 million in labor expenses related to increased headcount to support efforts to improve manufacturing processes and to develop and enhance products. Further, information technology and facilities expenses increased by a total of $658,000 in support of the increase in headcount, and travel expenses increased by $190,000 mainly related to customer requirements research. In addition to the increase in absolute dollars, research and development expenses increased to 14% of revenue for the first nine months of 2014, up from 11% for the same period in 2013, as both expenses were higher and revenues were lower for the first nine months of 2014.

Provision for Income Taxes

The effective tax rate differs from the statutory U.S. federal income tax rate of 34% primarily due to foreign income tax and the valuation allowance against the Company’s domestic deferred tax assets.

We recorded an income tax provision of $1.9 million for the first nine months of 2014 compared with $1.8 million for the same period in 2013. This provision is primarily related to taxes on income generated by our Swiss subsidiary. Unremitted earnings of foreign subsidiaries have been included in the consolidated financial statements without giving effect to the United States taxes that may be payable as it is not anticipated such earnings will be remitted to the United States. The Company has established a valuation allowance against its U.S. federal and state deferred tax assets, as well as the deferred tax asset of a foreign subsidiary, due to the uncertainty surrounding the realization of such assets as evidenced by the cumulative losses from operations through September 30, 2014. Management periodically evaluates the recoverability of the deferred tax assets and at such time as it is determined that it is more likely than not that deferred assets are realizable, the valuation allowance will be reduced accordingly.

At September 30, 2014, we have a cumulative valuation allowance recorded offsetting our worldwide net deferred tax assets of $59.5 million, of which the significant majority represents the valuation allowance on our U.S. net deferred tax asset. We have established a valuation allowance against our U.S. federal and state deferred tax assets due to the uncertainty surrounding the realization of such assets. Management periodically evaluates the recoverability of the deferred tax assets and at such time as it is determined that it is more likely than not that U.S. deferred tax assets are realizable, the valuation allowance will be reduced accordingly.

Liquidity and Capital Resources

Changes in Cash Flow

The following table summarizes our cash flows from operating, investing and financing activities for the nine months ended September 30, 2014 and 2013 (in thousands):

	Nine months ended September 30,
	2014			2013
Total cash provided by (used in):
Operating activities	$	6,251		$	24,066
Investing activities	(5,195		)	(14,016		)
Financing activities	3,096			(2,799		)
Effect of exchange rate changes on cash and cash equivalents	(4,001		)	1,057
Increase in cash and cash equivalents	$	151		$	8,308

Net cash provided by operating activities was $6.3 million for the nine months ended September 30, 2014. Operating cash flows related primarily to a net loss of $4.2 million, which included non-cash charges of $12.5 million. In addition, there was an increase in inventories of $8.2 million, which was partially offset by an increase in accounts payable and accrued

28

liabilities of $4.9 million, and an increase in deferred revenue and customer deposits of $2.2 million. The increase in inventories primarily relates to the build-up of inventory to meet anticipated demand in the next two quarters. The increase in accounts payable and accrued liabilities is primarily the result of the increase in inventories as well as the timing of payments at the end of the quarter.

The decrease in operating cash flows for the nine months ended September 30, 2014 compared with the nine months ended September 30, 2013 relates primarily to the net loss of $4.2 million for the nine months ended September 30, 2014 along with non-cash charges of $12.5 million, versus net income of $9.2 million, with non-cash charges of $10.9 million for the nine months ended September 30, 2013. In addition, there was an increase in accounts receivable of $1.3 million in the nine months ended September 30, 2014 as compared with a decrease of $4.1 million in the same period in the prior year. Also, inventory increased $8.2 million for the nine months ended September 30, 2014, compared with an increase of only $2.2 million in the same period in 2013.

Net cash used in investing activities was $5.2 million and $14.0 million for the nine months ended September 30, 2014 and 2013, respectively, and related primarily to capital expenditures. Capital expenditures in the nine months ended September 30, 2014 and 2013 were primarily focused on investments in increased production capacity, including equipment for our manufacturing facility in San Diego, California, our contract manufacturing operations in Shenzhen, China, and our new manufacturing facility in Peoria, Arizona, as well as investments in our corporate research and development center in San Diego, California. In addition, we had an increase in restricted cash of $2.3 million in the nine months ended September 30, 2013 related to a standby letter of credit that provided financial assurance for contractual obligations.

Net cash provided by financing activities was $3.1 million for the nine months ended September 30, 2014, compared with $2.8 million used in financing activities for the same period in 2013. Net cash provided by financing activities in the nine months ended September 30, 2014 primarily resulted from net proceeds on short term borrowings of $1.7 million and cash proceeds from our stock-based compensation plans of $1.4 million. Net cash used in financing activities in the nine months ended September 30, 2013 primarily resulted from net payments on long term and short term borrowings of $1.3 million, and an increase in restricted cash of $1.8 million related to a compensating balance with the bank as collateral for the forbearance agreement.

Liquidity

As of September 30, 2014, we had approximately $30.8 million in cash and cash equivalents, and working capital of $62.3 million. We have a credit facility providing for a $10.0 million revolving line of credit, of which $3.0 million has been drawn upon and is outstanding as of September 30, 2014. Based upon the events of default discussed below, the bank's obligation to extend any further credit has ceased and terminated. We currently owe $1.0 million under the equipment term loan provided by the same credit facility.

As of September 30, 2014, the amount of cash and short-term investments held by foreign subsidiaries was $28.2 million. If these funds are needed for our operations in the U.S. in the future, we may be required to accrue and pay taxes to repatriate these funds at a rate of approximately 5%. We intend to permanently reinvest earnings of our foreign subsidiaries.

On June 3, 2014, we filed a shelf registration statement on Form S-3 with the SEC to, from time to time, sell up to $125 million of our common stock, warrants, debt securities or units. To date, we have not raised any funds under this shelf registration statement. In the future, we may decide to supplement existing cash and planned cash flow from operations by borrowing additional funds or by issuing additional debt or equity.

29

Credit Facility

In December 2011, we obtained a secured credit facility in the form of a revolving line of credit (the “Revolving Line of Credit”) and an equipment term loan (the “Equipment Term Loan”) (together, the “Credit Facility”). As amended, the Revolving line of Credit was available up to a maximum of $10.0 million. In general, amounts borrowed under the Credit Facility are secured by a lien on all of our assets other than our intellectual property. In addition, under the credit agreement, as amended, we are required to pledge 100% of our equity interests in our Swiss subsidiary. We have also agreed not to encumber any of our intellectual property. The agreement contains certain restrictive covenants that limit our ability to, amongst other things; (i) incur additional indebtedness or guarantees; (ii) create liens or other encumbrances on our property; (iii) enter into a merger or similar transaction; (iv) invest in another entity; (v) declare or pay dividends; and (vi) invest in fixed assets in excess of a defined dollar amount. Repayment of amounts owed pursuant to the Credit Facility may be accelerated in the event that we are in violation of any of the representations, warranties and covenants made in the credit agreement, including certain financial covenants. The financial covenants that we must meet during the term of the credit agreement, as amended, include quarterly minimum liquidity ratios, minimum cash requirements and net loss targets. Borrowings under the Credit Facility bear interest, payable monthly, at either (i) the bank's prime rate or (ii) LIBOR plus 2.25%, at our option subject to certain limitations. Further, we incur an unused commitment fee, payable quarterly, equal to 0.25% per annum of the average daily unused amount of the Revolving Line of Credit.

The Equipment Term Loan was available to finance 80% of eligible equipment purchases made between April 1, 2011 and April 30, 2012. During this period, we borrowed $5.0 million under the Equipment Term Loan. In March 2014, the Company borrowed $3.0 million under the Revolving Line of Credit, and no other amounts have been borrowed to date under the Revolving Line of Credit.

As of December 31, 2013, we were not in compliance with the financial covenant pertaining to the quarterly EBITDA target for the quarter ended December 31, 2013. As a result of this noncompliance, borrowings outstanding under the Credit Facility were classified as a current obligation in the consolidated balance sheet as of December 31, 2013.

On August 29, 2014, we entered into an amendment to the Credit Facility with the bank where any existing defaults were waived. Under the amendment, the financial covenants that we must meet during the term of the credit agreement were revised to include quarterly minimum liquidity ratios, minimum cash requirements and net loss targets.

As of September 30, 2014, the Company was not in compliance with the financial covenant pertaining to the requirement to maintain a quarterly minimum liquidity ratio. As a result of this noncompliance, the bank's obligation to extend any further credit has ceased and terminated and the outstanding debt balance is immediately callable by the bank.

As of September 30, 2014, $1.0 million was outstanding under the Equipment Term Loan and the applicable interest rate was LIBOR plus 2.25% (2.5% as of September 30, 2014). If the bank does not exercise its right to accelerate repayment, under the original terms of the Credit Facility, principal and interest under the Equipment Term Loan are payable in 36 equal monthly installments such that the Equipment Term Loan is fully repaid by the maturity date of April 30, 2015, but may be prepaid in whole or in part at any time. As of September 30, 2014, $3.0 million was outstanding under the Revolving Line of Credit and the applicable interest rate was LIBOR plus 2.25% (2.5% as of September 30, 2014). If the bank does not exercise its right to accelerate repayment, under the amended terms of the Credit Facility, the amount outstanding under the Revolving Line of Credit is scheduled to be repaid by February 28, 2015.

Short-term and Long-term Borrowings

Short-term borrowings

Maxwell’s Swiss subsidiary, Maxwell SA, has a 3.0 million Swiss Franc-denominated (approximately $3.1 million as of September 30, 2014) credit agreement with a Swiss bank, which renews semi-annually and bears interest at 1.6%. Borrowings under the short-term loan agreement are unsecured and as of September 30, 2014 and December 31, 2013, the full amount of the loan was drawn.

Maxwell SA also has a 2.0 million Swiss Franc-denominated (approximately $2.1 million as of September 30, 2014) credit agreement with a Swiss bank, which renews annually and bears interest at 1.7%. Borrowings under the credit agreement are unsecured and as of September 30, 2014 and December 31, 2013, the full amount available under the credit line was drawn.

Maxwell SA also has a 1.0 million Swiss Franc-denominated (approximately $1.0 million as of September 30, 2014) credit agreement with another Swiss bank, and the available balance of the line can be withdrawn or reduced by the bank at any time. As of September 30, 2014 and December 31, 2013, no amounts were drawn under the credit line. Interest rates applicable to any draws on the line will be determined at the time of draw.

30

Long-term borrowings

The Company has various financing agreements for vehicles. These agreements are for up to a five year repayment period with interest rates ranging from 1.9% to 5.1%. At September 30, 2014 and December 31, 2013, $110,000 and $179,000, respectively, was outstanding under these financing agreements.

Critical Accounting Estimates

We describe our significant accounting policies in Note 1, Description of Business and Summary of Significant Accounting Policies, of the notes to consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2013. We discuss our critical accounting estimates in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2013. There have been no significant changes in our significant accounting policies or critical accounting estimates since the end of fiscal 2013.

Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”). The standard provides companies with a single model for accounting for revenue arising from contracts with customers and supersedes current revenue recognition guidance, including industry-specific revenue guidance. The core principle of the model is to recognize revenue when control of the goods or services transfers to the customer, as opposed to recognizing revenue when the risks and rewards transfer to the customer under the existing revenue guidance. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016. Early adoption is not permitted. The guidance permits companies to either apply the requirements retrospectively to all prior periods presented, or apply the requirements in the year of adoption, through a cumulative adjustment.  The Company is in the process of evaluating the impact of adoption on its consolidated financial statements.    

In August 2014, the FASB issued ASU No. 2014-15, Disclosure of Uncertainties About an Entity’s Ability to Continue as a Going Concern. The standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued and provides guidance on determining when and how to disclose going concern uncertainties in the financial statements. Certain disclosures will be required if conditions give rise to substantial doubt about an entity’s ability to continue as a going concern. ASU 2014-15 applies to all entities and is effective for annual and interim reporting periods ending after December 15, 2016, with early adoption permitted. The Company does not expect that the adoption of this standard will have a material effect on its financial statements.

Off Balance Sheet Arrangements

None.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We face exposure to financial market risks, including adverse movements in foreign currency exchange rates and changes in interest rates. These exposures may change over time and could have a material adverse impact on our financial results. We have not entered into or invested in any instruments that are subject to market risk, except as follows:

31

Foreign Currency Risk

Our primary foreign currency exposure is related to our subsidiary in Switzerland, Maxwell SA. Maxwell SA has Euro and local currency (Swiss Franc) revenue and operating expenses, as well as local currency loans. Changes in these currency exchange rates impact the reported amount (U.S. dollar) of revenue, expenses and debt. As part of our risk management strategy, we use forward contracts to hedge certain foreign currency exposures. Our objective is to offset gains and losses resulting from these exposures with gains and losses on the forward contracts, thereby reducing volatility of earnings. We use the forward contracts to hedge certain monetary assets and liabilities, primarily receivables and payables, denominated in a foreign currency. The change in fair value of these instruments represents a natural hedge as their gains and losses partially offset the changes in the fair value of the underlying monetary assets and liabilities due to movements in currency exchange rates. As of September 30, 2014, the impact of a theoretical detrimental change in foreign currency exchange rates of 10% on the foreign currency forward contracts would result in a hypothetical loss of $3.6 million, however, considering the offsetting impact of such a theoretical change in exchange rates on the underlying assets and liabilities being hedged, the hypothetical loss is only $14,000, which would be recorded in income from continuing operations in the consolidated statement of operations. For local currency debt carried by our Swiss subsidiary, the impact of a hypothetical 10% detrimental change in foreign currency exchange rates would result in a hypothetical loss of $596,000, which would be recorded in accumulated other comprehensive income on the consolidated balance sheet.

Interest Rate Risk

At September 30, 2014, we had approximately $9.3 million in debt, $44,000 of which is classified as long-term debt. Changes in interest rates may affect the consolidated balance sheet and statement of operations. The impact on earnings or cash flow during the next fiscal year from a change of 100 basis points (or 1%) in the interest rate would have a $93,000 effect on interest expense.

Fair Value Risk

We had a net pension asset of $10.6 million at September 30, 2014 and December 31, 2013. As of the last fair value measurement date of December 31, 2013, the net pension asset included plan assets with a fair value of $43.1 million. The plan assets consisted of 57% debt and equity securities, 40% real estate and 3% of cash and cash equivalents. The fair values of debt and equity securities are determined based on quoted prices in active markets for identical assets and are subject to interest rate risk. The fair value measurement of the real estate is subject to the real estate market forces in Switzerland. We manage our risk by having a diversified portfolio.

Item 4. Controls and Procedures

We are committed to maintaining disclosure controls and procedures designed to ensure that information required to be disclosed in our periodic reports filed under the Securities and Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2014, as such term is defined under Rule 13a-15(e) promulgated under the Exchange Act. Based on this evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report on Form 10-Q.

There have been no changes in our internal control over financial reporting during the quarter ended September 30, 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

32

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

The information set forth under Note 9 of Notes to Unaudited Condensed Consolidated Financial Statements, included in Part I, Item 1 of this report, is incorporated herein by reference.

Item 1A. Risk Factors

There have been no material changes from the risk factors disclosed in Part I, Item 1A, of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013, which are incorporated herein by reference.

Item 2, 3, 4 and 5 are not applicable and have been omitted

Item 6. Exhibits

Exhibit Number	Description of Document
10.34	Sixth Amendment to Credit Note dated August 29, 2014, between Maxwell Technologies, Inc. and Wells Fargo Bank, N.A. *
10.35	Fifth Amended and Restated Revolving Credit Note dated August 29, 2014, between Maxwell Technologies, Inc. and Wells Fargo Bank, N.A. *
31.1	Certification of Principal Executive Officer pursuant to Rule 13a-14(a) (Section 302 Certification) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. *
31.2	Certification of Principal Financial Officer pursuant to Rule 13a-14(a) (Section 302 Certification) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. *
32	Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350 (Section 906 Certification), as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. *
101	The following financial statements and footnotes from the Maxwell Technologies, Inc. Quarterly Report on Form 10-Q for the quarter ended September 30, 2014 formatted in Extensible Business Reporting Language (XBRL): (i) Condensed Consolidated Balance Sheets; (ii) Condensed Consolidated Statements of Operations; (iii) Condensed Consolidated Statements of Comprehensive Income (Loss) (iv) Condensed Consolidated Statements of Cash Flows; and (v) the Notes to Condensed Consolidated Financial Statements. *

_________ 

* Filed herewith.

33

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		MAXWELL TECHNOLOGIES, INC.
Date:	October 23, 2014	By:	/s/ Franz Fink
			Franz Fink
			President and Chief Executive Officer
Date:	October 23, 2014	By:	/s/ Kevin S. Royal
			Kevin S. Royal
			Senior Vice President, Chief Financial Officer, Treasurer and Secretary

34

EX-10.34

Exhibit 10.34

SIXTH AMENDMENT TO CREDIT AGREEMENT

This Sixth Amendment to Credit Agreement (this “Amendment”) is entered into as of August 29, 2014, by and between WELLS FARGO BANK, NATIONAL ASSOCIATION (“Bank”) and MAXWELL TECHNOLOGIES, INC. (“Borrower”).

RECITALS

Borrower and Bank are parties to that certain Credit Agreement dated as of December 5, 2011, as amended from time to time, including but without limitation by that certain First Amendment to Credit Agreement dated as of October 31, 2013, that certain Second Amendment to Credit Agreement dated as of December 5, 2013, that certain Third Amendment to Credit Agreement dated as of February 5, 2014, that certain Forbearance and Fourth Amendment to Credit Agreement dated as of April 30, 2014 and that certain Forbearance and Fifth Amendment to Credit Agreement dated as of June 30, 2014 (the “Agreement”).

Borrower has informed Bank that Borrower is in default under the Agreement due to (i) Borrower’s violation of Section 4.9(a) of the Agreement as a result of Borrower’s failure to maintain at all times the Minimum Liquidity Coverage Ratio and (ii) Borrower’s violation of Section 4.9(c) of the Credit Agreement as a result of Borrower’s failure to maintain the required EBITDA set forth therein for the quarter ending June 30, 2014 (collectively, the “Existing Defaults”). The parties desire to amend the Agreement in accordance with the terms of this Amendment.

NOW, THEREFORE, the parties agree as follows:

1.All references in the Loan Documents (as defined in the Agreement) to the “Line of Credit Note” shall hereafter mean and refer to a promissory note dated as of even date herewith, the “Fifth Amended and Restated Revolving Line of Credit Note”.

2.Section 1.1(a) of the Agreement is hereby amended and restated in its entirety to read as follows:

“(a)Line of Credit. Subject to the terms and conditions of this Agreement, Bank hereby agrees to make advances to Borrower from time to time up to and including February 28, 2015, not to exceed at any time the aggregate principal amount of Ten Million Dollars ($10,000,000) (“Line of Credit”), the proceeds of which shall be used to finance Borrower’s working capital requirements and general corporate purposes. Borrower’s obligation to repay advances under the Line of Credit shall be evidenced by a promissory note dated as of August 29, 2014 as amended, restated, modified or supplemented from time to time (“Line of Credit Note”), all terms of which are incorporated herein by this reference.”

3.Section 1.6 of the Agreement is hereby amended and restated in its entirety to read as follows:

“SECTION 1.6. GUARANTIES. The payment and performance of all Indebtedness and other obligations of Borrower to Bank hereunder shall be guaranteed jointly and severally by all present and future Material Subsidiaries which guaranties shall be secured by unconditional, continuing pledges and security interests in and to all of the assets and properties of such Material Subsidiaries (any such Material Subsidiary, together with any other guarantors of the Line of Credit, the Equipment Term Commitment and/or any other Indebtedness of Borrower to Bank from time to time, each a “Guarantor” and collectively, “Guarantors”), as evidenced by and subject to the terms of guaranties in form and substance satisfactory to Bank (the “Guaranty”). Upon the creation or acquisition of any new Material Subsidiary or of any Subsidiary becoming a Material Subsidiary, Borrower and such Subsidiary shall: (a) promptly notify Bank of the creation or acquisition of such Material Subsidiary, (b) take all such action as may be reasonably required by Bank to cause such Material Subsidiary to guarantee the obligations of Borrower hereunder and grant such pledges and security interests in all of its properties and assets to secure payment and performance of such obligations, and (c) take all such action as may be reasonably required by Bank to grant and pledge to Bank a first-priority security interest in the stock or other equity interests of, and any indebtedness owing from, such Material Subsidiary.

Notwithstanding anything to the contrary contained herein, (i) no Foreign Subsidiary shall be required to provide a Guaranty and (ii) Borrower shall not be required to pledge more than sixty five percent (65%) of the of the total combined voting power of all classes of stock entitled to vote the shares of capital stock of any such Foreign Subsidiary (other than Maxwell Technologies SA).

As used herein, “Subsidiary” is, as to any person or entity, a corporation, partnership, limited liability company or other entity of which shares of stock or other ownership interests having ordinary voting power (other than stock or such other ownership interests having such power only by reason of the happening of a contingency) to elect a majority of the board of directors or other managers of such corporation, partnership or other entity are at the time owned, or the management of which is otherwise controlled, directly or indirectly through one or more intermediaries, or both, by such person or entity.

As used herein, “Material Subsidiary” means (i) Maxwell Technologies SA and (ii) as of the last day of each of Borrower’s fiscal quarters, any of Borrower’s Subsidiaries that has (i) total revenues for the two quarter period ending on such date equal to or greater than two percent (2.0%) of Borrower’s and its consolidated Subsidiaries’ total revenues during such six (6) month period or (ii) owns or holds assets as of such date equal to or greater than two percent (2.0%) of Borrower’s and its consolidated Subsidiaries’ total assets as of such date.

As used herein, “Foreign Subsidiary” means any Subsidiary of Borrower not incorporated or organized under the laws of one of the States or jurisdictions of the United States.”

4.Section 3.3(b) of the Agreement is hereby amended and restated in its entirety to read as follows:

“(b)By no later than October 29, 2014, a pledge of one hundred percent (100%) of the Shares of Maxwell Technologies SA.”

5.Section 4.9 of the Agreement is hereby amended and restated in its entirety to read as follows:

“SECTION 4.9. FINANCIAL CONDITION. Maintain Borrower’s financial condition as follows using generally accepted accounting principles consistently applied and used consistently with prior practices (except to the extent modified by the definitions herein):

(a)Quick Ratio not less than 1.2 to 1.0 at any time, measured as of the end of each fiscal quarter, with “Quick Ratio” defined as the ratio of (i) the sum of (1) consolidated unrestricted cash plus (2) net consolidated accounts receivable, and (ii) divided by the sum of (1) total consolidated current liabilities plus (2) outstanding advances under the Line of Credit (including the Letters of Credit Sublimit and Credit Card Sublimit but excluding any cash-secured Letter of Credit).

(b)Borrower shall maintain at least Twenty Million Dollars ($20,000,000) in consolidated unrestricted cash at all times.

(c)Quarterly net income after taxes (determined in accordance with GAAP) not less than (a) negative Four Million Dollars (-$4,000,000) for the quarter ending September 30, 2014, and (b) negative One Million Dollars (-$1,000,000) for the quarter ending December 31, 2014.”

6.Section 4.12 of the Agreement hereby is amended and restated in its entirety to read as follows:

“SECTION 4.12 COLLATERAL AUDIT. Permit Bank to perform audits of the Collateral at Borrower’s sole cost and expense, which collateral audits will be conducted at Bank’s request; provided, that, (i) so long as no Event of Default has occurred and is continuing, Borrower shall not be required to pay for more than one (1) collateral audit in any calendar year at a cost of not more than Ten Thousand Dollars ($10,000) and (ii) a collateral audit shall be completed by Bank after August 29, 2014 but prior to the date on which the aggregate amount of outstanding advances under the Line of Credit exceeds Three Million Dollars ($3,000,000).”

7.Section 5.2 of the Agreement hereby is amended and restated in its entirety to read as follows:

“SECTION 5.2. CAPITAL EXPENDITURES. Make any additional investment in fixed assets in any fiscal year in excess of an aggregate of Fifteen Million Dollars ($15,000,000) plus any unused amount available from the immediately preceding year from and after January 1, 2014.”

8.The Compliance Certificate attached to the Agreement hereby is replaced with the Compliance Certificate attached hereto.

9.Borrower acknowledges and Bank hereby waives Existing Defaults.

10.No course of dealing on the part of Bank or its officers, nor any failure or delay in the exercise of any right by Bank, shall operate as a waiver thereof, and any single or partial exercise of any such right shall not preclude any later exercise of any such right. Bank’s failure at any time to require strict performance by Borrower of any provision shall not affect any right of Bank thereafter to demand strict compliance and performance. Any suspension or waiver of a right must be in writing signed by an officer of Bank.

11.Unless otherwise defined, all initially capitalized terms in this Amendment shall be as defined in the Agreement. The Agreement, as amended hereby, shall be and remain in full force and effect in accordance with its respective terms and hereby is ratified and confirmed in all respects. Except as expressly set forth herein, the execution, delivery, and performance of this Amendment shall not operate as a waiver of, or as an amendment of, any right, power, or remedy of Bank under the Agreement, as in effect prior to the date hereof.

12.Borrower represents and warrants that the Representations and Warranties contained in the Agreement are true and correct as of the date of this Amendment, and that no Event of Default (other than the Existing Defaults) has occurred and is continuing.

13.As a condition to the effectiveness of this Amendment, Bank shall have received, in form and substance satisfactory to Bank:

(a)this Amendment, duly executed by Borrower;

(b)Corporate Borrowing Resolutions in the form attached hereto;

(c)the Fifth Amended and Restated Revolving Line of Credit Note, duly executed by Borrower; and

(d)all reasonable fees and expenses incurred through the date of this Amendment, which may be debited from any of Borrower's accounts.

14.This Amendment may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one instrument.

[Balance of Page Intentionally Left Blank]

IN WITNESS WHEREOF, the undersigned have executed this Amendment as of the first date above written.

MAXWELL TECHNOLOGIES, INC.

By:/s/ Kevin Royal

Title:Sr. V.P. and Chief Financial Officer

WELLS FARGO BANK, NATIONAL ASSOCIATION

By:/s/ Dennis Kim

Title:Vice President

[Signature Page to Sixth Amendment to Credit Agreement]

EX-10.35

Exhibit 10.35

FIFTH AMENDED AND RESTATED REVOLVING LINE OF CREDIT NOTE

$10,000,000.00	San Diego, California
	August 29, 2014

FOR VALUE RECEIVED, the undersigned MAXWELL TECHNOLOGIES, INC. (“Borrower”) promises to pay to the order of WELLS FARGO BANK, NATIONAL ASSOCIATION (“Bank”) at its office at 10421 Wateridge Court, Suite 150, San Diego, CA 92121, or at such other place as the holder hereof may designate, in lawful money of the United States of America and in immediately available funds, the principal sum of Ten Million Dollars ($10,000,000.00), or so much thereof as may be advanced and be outstanding, with interest thereon, to be computed on each advance from the date of its disbursement as set forth herein.

DEFINITIONS:

As used herein, the following terms shall have the meanings set forth after each, and any other term defined in this Note shall have the meaning set forth at the place defined:

(a)“Business Day” means any day except a Saturday, Sunday or any other day on which commercial banks in California are authorized or required by law to close.

(b)“Fixed Rate Term” means a period commencing on a Business Day and continuing for a period of thirty (30) days, during which all or a portion of the outstanding principal balance of this Note bears interest determined in relation to LIBOR; provided however, that no Fixed Rate Term may be selected for a principal amount less than One Million Dollars ($1,000,000); and provided further, that no Fixed Rate Term shall extend beyond the scheduled maturity date hereof. If any Fixed Rate Term would end on a day which is not a Business Day, then such Fixed Rate Term shall be extended to the next succeeding Business Day

(c)“LIBOR” means the rate per annum (rounded upward, if necessary, to the nearest whole 1/8 of 1%) and determined pursuant to the following formula:

LIBOR =	Base LIBOR
	100% - LIBOR Reserve Percentage

(i)“Base LIBOR” means the rate per annum for United States dollar deposits quoted by Bank for the purpose of calculating effective rates of interest for loans making reference to LIBOR, as the Inter-Bank Market Offered Rate, with the understanding that such rate is quoted by Bank for the purpose of calculating effective rates of interest for loans making reference thereto, on the first day of a Fixed Rate Term for delivery of funds on said date for a period of thirty (30) days and in an amount approximately equal to the principal amount to which such Fixed Rate Term applies. Borrower understands and agrees that Bank may base its quotation of the Inter-Bank Market Offered Rate upon such offers or other market indicators of the Inter-Bank Market as Bank in its discretion deems appropriate including, but not limited to, the rate offered for U.S. dollar deposits on the London Inter-Bank Market.

(ii)“LIBOR Reserve Percentage” means the reserve percentage prescribed by the Board of Governors of the Federal Reserve System (or any successor) for “Eurocurrency Liabilities” (as defined in Regulation D of the Federal Reserve Board, as amended), adjusted by Bank for expected changes in such reserve percentage during a one (1) month period.

(d)“Prime Rate” means at any time the rate of interest most recently announced within Bank at its principal office as its Prime Rate, with the understanding that the Prime Rate is one of Bank’s base rates and serves as the

basis upon which effective rates of interest are calculated for those loans making reference thereto, and is evidenced by the recording thereof after its announcement in such internal publication or publications as Bank may designate.

INTEREST:

(a)Interest. The outstanding principal balance of this Note shall bear interest (computed on the basis of a three hundred sixty (360) day year, actual days elapsed) either (i) at a floating rate per annum equal to the Prime Rate in effect from time to time or (ii) at a fixed rate per annum determined by Bank to be two and one quarter of one percent (2.25%) above LIBOR in effect on the first day of the Fixed Rate Term. When interest is determined in relation to the Prime Rate, each change in the interest rate shall become effective each Business Day that the Bank determines that the Prime Rate has changed. Bank is hereby authorized to note the date, principal amount and interest rate applicable thereto and any payments made thereon on Bank’s books and records (either manually or by electronic entry) and/or on any schedule attached to this Note, which notations shall be prima facie evidence of the accuracy of the information noted.

(b)Selection of Interest Rate Options. At any time any portion of this Note bears interest determined in relation to LIBOR for a Fixed Rate Term, it may be continued by Borrower at the end of the Fixed Rate Term so that all or a portion thereof bears interest determined in relation to the Prime Rate or to LIBOR for a new Fixed Rate Term. At any time any portion of this Note bears interest determined in relation to the Prime Rate, Borrower may at any time convert all or a portion thereof so that it bears interest determined in relation to LIBOR for a Fixed Rate Term. At such time as Borrower requests an advance hereunder or wishes to select an interest rate determined in relation to the Prime Rate or a Fixed Rate Term for all or a portion of the outstanding principal balance hereof, and at the end of each Fixed Rate Term, Borrower shall give Bank notice specifying: (i) the interest rate option selected by Borrower and (ii) the principal amount subject thereto. Any such notice may be given by telephone (or such other electronic method as Bank may permit) so long as, with respect to each LIBOR selection for a Fixed Rate Term, (A) if requested by Bank, Borrower provides to Bank written confirmation thereof not later than three (3) Business Days after such notice is given, and (B) such notice is given to Bank (i) prior to 10:00 a.m. Pacific time, on the first day of the Fixed Rate Term, or (ii) at a later time during any Business Day if Bank, at its sole option but without obligation to do so, accepts Borrower’s notice and quotes a fixed rate to Borrower. If Borrower does not immediately accept a fixed rate when quoted by Bank, the quoted rate shall expire and any subsequent LIBOR request from Borrower shall be subject to a redetermination by Bank of the applicable fixed rate. If no specific designation of interest is made at the time any advance is requested hereunder or at the end of any Fixed Rate Term, Borrower shall be deemed to have made a Prime Rate interest selection for such advance or the principal amount to which such Fixed Rate Term applied.

(c)Taxes and Regulatory Costs. Borrower shall pay to Bank immediately upon demand, in addition to any other amounts due or to become due hereunder, any and all (i) withholdings, interest equalization taxes, stamp taxes or other taxes (except income and franchise taxes) imposed by any domestic or foreign governmental authority and related in any manner to LIBOR, and (ii) future, supplemental, emergency or other changes in the LIBOR Reserve Percentage, assessment rates imposed by the Federal Deposit Insurance Corporation, or similar requirements or costs imposed by any domestic or foreign governmental authority or resulting from compliance by Bank with any request or directive (whether or not having the force of law) from any central bank or other governmental authority and related in any manner to LIBOR to the extent they are not included in the calculation of LIBOR. In determining which of the foregoing are attributable to any LIBOR option available to Borrower hereunder, any reasonable allocation made by Bank among its operations shall be conclusive and binding upon Borrower.

(d)Payment of Interest. Interest accrued on this Note shall be payable on the last day of each month, commencing December 31, 2011, in the case of loans accruing interest at Prime Rate, and on the last day of each Fixed Rate Term for loans accruing interest for a Fixed Rate Term.

(e)Default Interest. From and after the maturity date of this Note, or such earlier date as all principal owing hereunder becomes due and payable by acceleration or otherwise, or at Bank’s option upon the occurrence, and during the continuance of an Event of Default, the outstanding principal balance of this Note shall bear interest at an increased rate per annum (computed on the basis of a three hundred sixty (360) day year, actual days elapsed) equal to five percent (5%) above the rate of interest from time to time applicable to this Note.

BORROWING AND REPAYMENT:

(a)Borrowing and Repayment. Borrower may from time to time during the term of this Note borrow, partially or wholly repay its outstanding borrowings, and reborrow, subject to all of the limitations, terms and conditions

of this Note, the Credit Agreement and any document executed in connection with or governing this Note; provided however, that the total outstanding borrowings under this Note shall not at any time exceed the principal amount stated above. The unpaid principal balance of this obligation at any time shall be the total amounts advanced hereunder by the holder hereof less the amount of principal payments made hereon by or for Borrower, which balance may be endorsed hereon from time to time by the holder. The outstanding principal balance of this Note shall be due and payable in full on February 28, 2015 or such earlier date as all principal owing hereunder becomes due and payable by acceleration or otherwise.

(b)Advances. Advances hereunder, to the total amount of the principal sum stated above, may be made by the holder at the oral or written request of (i) Borrower’s chief executive officer or chief financial officer, or their designees, any one acting alone, who are authorized to request advances and direct the disposition of any advances until written notice of the revocation of such authority is received by the holder at the office designated above, or (ii) any person, with respect to advances deposited to the credit of any deposit account of Borrower, which advances, when so deposited, shall be conclusively presumed to have been made to or for the benefit of Borrower regardless of the fact that persons other than those authorized to request advances may have authority to draw against such account. The holder shall have no obligation to determine whether any person requesting an advance is or has been authorized by Borrower.

(c)Application of Payments. Each payment made on this Note shall be credited first, to any interest then due and second, to the outstanding principal balance hereof. All payments credited to principal shall be applied first, to the outstanding principal balance of this Note which bears interest determined in relation to the Prime Rate, if any, and second, to the outstanding principal balance of this Note which bears interest determined in relation to LIBOR.

PREPAYMENT:

(a)Prime Rate. Borrower may prepay principal on any portion of this Note which bears interest determined in relation to the Prime Rate at any time, in any amount and without penalty.

(b)LIBOR. Borrower may prepay principal on any portion of this Note which bears interest determined in relation to LIBOR for a fixed rate at any time and in the minimum amount of One Million Dollars ($1,000,000); providedhowever, that if the outstanding principal balance of this Note is less than said amount, the minimum prepayment amount shall be the entire outstanding principal balance thereof. In consideration of Bank providing this prepayment option to Borrower, or if any such portion of this Note shall become due and payable at any time prior to the last day of the Fixed Rate Term by acceleration or otherwise, Borrower shall pay to Bank immediately upon demand a fee, calculated as follows for each such Fixed Rate Term:

(i) Determine the amount of interest which would have accrued on the amount prepaid at the interest rate applicable to such amount had it remained outstanding until the last day of the Fixed Rate Term.

(ii) Subtract from the amount determined in (i) above the amount of interest which would have accrued for the same month on the amount prepaid for the remaining term of such Fixed Rate Term at LIBOR in effect on the date of prepayment for new loans made for such term and in a principal amount equal to the amount prepaid.

(iii) If the result obtained in (ii) for any Fixed Rate Term is greater than zero, discount that difference by LIBOR used in (ii) above.

Borrower acknowledges that prepayment of such amount may result in Bank incurring additional costs, expenses and/or liabilities, and that it is difficult to ascertain the full extent of such costs, expenses and/or liabilities. Borrower, therefore, agrees to pay the above-described prepayment fee and agrees that said amount represents a reasonable estimate of the prepayment costs, expenses and/or liabilities of Bank. If Borrower fails to pay any prepayment fee when due, the amount of such prepayment fee shall thereafter bear interest until paid at a rate per annum seven and three-quarters of one percent (7.75%) above the Prime Rate in effect from time to time (computed on the basis of a three hundred sixty (360) day year, actual days elapsed).

EVENTS OF DEFAULT:

This Note is made pursuant to and is subject to the terms and conditions of that certain Credit Agreement between Borrower and Bank dated as of the date hereof, as amended, restated, modified or supplemented from time

to time (the “Credit Agreement”). Any default in the payment or performance of any obligation under this Note, or any defined event of default under the Credit Agreement, shall constitute an “Event of Default” under this Note.

MISCELLANEOUS:

(a)Remedies. Upon the occurrence and during the continuance of any Event of Default, the holder of this Note, at the holder’s option, may declare all sums of principal and interest outstanding hereunder to be immediately due and payable without presentment, demand, notice of nonperformance, notice of protest, protest or notice of dishonor, all of which are expressly waived by Borrower, and the obligation, if any, of the holder to extend any further credit hereunder shall immediately cease and terminate. Borrower shall pay to the holder immediately upon demand the full amount of all payments, advances, charges, costs and expenses, including reasonable attorneys’ fees (to include outside counsel fees and all allocated costs of the holder’s in-house counsel), expended or incurred by the holder in connection with the enforcement of the holder’s rights and/or the collection of any amounts which become due to the holder under this Note, and the prosecution or defense of any action in any way related to this Note, including without limitation, any action for declaratory relief, whether incurred at the trial or appellate level, in an arbitration proceeding or otherwise, and including any of the foregoing incurred in connection with any bankruptcy proceeding (including without limitation, any adversary proceeding, contested matter or motion brought by Bank or any other person) relating to Borrower or any other person or entity.

(b)Obligations Joint and Several. Should more than one person or entity sign this Note as a Borrower, the obligations of each such Borrower shall be joint and several.

(c)Governing Law. This Note shall be governed by and construed in accordance with the laws of the State of California.

[Balance of Page Intentionally Left Blank]

IN WITNESS WHEREOF, the undersigned has executed this Note as of the date first written above.

MAXWELL TECHNOLOGIES, INC.

By:/s/ Kevin Royal

Name: Kevin Royal

Title:Sr. V.P. and Chief Financial Officer

EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, Franz Fink, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Maxwell Technologies, Inc. for the quarter ended September 30, 2014.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	October 23, 2014	MAXWELL TECHNOLOGIES, INC.
		By:	/s/ Franz Fink
			Franz Fink
			President and Chief Executive Officer
			(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

I, Kevin S. Royal, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Maxwell Technologies, Inc. for the quarter ended September 30, 2014.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	October 23, 2014	MAXWELL TECHNOLOGIES, INC.
		By:	/s/ Kevin S. Royal
			Kevin S. Royal
			Senior Vice President, Chief Financial Officer,
			Treasurer and Secretary
			(Principal Financial Officer)

EX-32

Exhibit 32

Certification of Periodic Financial Report by the Principal Executive Officer and

Principal Financial Officer

Solely for the purpose of complying with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, we, the undersigned Chief Executive Officer and Chief Financial Officer of Maxwell Technologies, Inc. (the “Company”), hereby certify that, based on our knowledge, the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2014 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	October 23, 2014	MAXWELL TECHNOLOGIES, INC.
		By:	/s/ Franz Fink
			Franz Fink
			President and Chief Executive Officer
			(Principal Executive Officer)
Date:	October 23, 2014	By:	/s/ Kevin S. Royal
			Kevin S. Royal
			Senior Vice President, Chief Financial Officer,
			Treasurer and Secretary
			(Principal Financial Officer)

XML

Defined Benefit Plan (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Schedule of components of net periodic pension income
Service cost	$ 211	$ 207	$ 645	$ 618
Interest cost	174	125	532	374
Expected return on plan assets	(446)	(383)	(1,361)	(1,145)
Prior service cost amortization	35	11	107	33
Deferred loss amortization	0	45	0	135
Net periodic pension income	$ (26)	$ 5	$ (77)	$ 15

XML

Foreign Currency Derivative Instruments (Details Textual) (USD $) In Millions, unless otherwise specified	Sep. 30, 2014
Foreign Currency Derivative Instruments (Textual) [Abstract]
Notional amount of foreign currency forward contracts not designated as hedges	$ 35.0

XML

Description of Business and Basis of Presentation (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014 Segment manufacturing_location
Description of Business and Basis of Presentation [Line Items]
Deferred Tax Assets, Valuation Allowance	$ 59,500,000		$ 59,500,000
Deferred Revenue, Additions	3,300,000	4,500,000
Description of Business and Basis of Presentation (Textual) [Abstract]
Manufacturing locations			3
Operating segments			1
Warranty period, minimum, in years			1 year
Warranty period, maximum, in years			4 years
Cost of Inventory Shipped	2,303,000	2,490,000	2,303,000
Deferred revenue and customer deposits	$ 2,826,000	$ 1,043,000	$ 2,826,000

XML

Stock Plans (Details Textual) (USD $)	9 Months Ended		3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended		3 Months Ended			9 Months Ended
	Sep. 30, 2014 share_based_compensation_plan	Sep. 30, 2013	Sep. 30, 2014 Outstanding options to purchase common stock	Sep. 30, 2013 Outstanding options to purchase common stock	Sep. 30, 2014 Outstanding options to purchase common stock	Sep. 30, 2013 Outstanding options to purchase common stock	Sep. 30, 2014 Restricted Stock Awards	Sep. 30, 2013 Restricted Stock Awards	Sep. 30, 2014 Restricted Stock Awards	Sep. 30, 2013 Restricted Stock Awards	Sep. 30, 2014 Restricted stock unit awards	Sep. 30, 2013 Restricted stock unit awards	Sep. 30, 2014 Restricted stock unit awards	Sep. 30, 2013 Restricted stock unit awards	Sep. 30, 2014 Employee Stock Purchase Plan	Sep. 30, 2013 Employee Stock Purchase Plan	Sep. 30, 2014 Employee Stock Purchase Plan	Sep. 30, 2013 Employee Stock Purchase Plan	Jun. 30, 2013 Chief Financial Officer [Member]	Sep. 30, 2014 Director [Member] Restricted stock unit awards	Sep. 30, 2013 Director [Member] Restricted stock unit awards	Sep. 30, 2014 Director [Member] Restricted stock unit awards	Sep. 30, 2013 Director [Member] Restricted stock unit awards	Sep. 30, 2014 Service Based Restricted Stock [Member] Restricted stock unit awards	Sep. 30, 2014 Performance Based Restricted Stock [Member] Restricted stock unit awards
Stock Plans (Textual) [Abstract]
Stock-based compensation plans	2
Stock-based compensation expense	$ 2,934,000	$ 2,622,000	$ 33,000	$ (32,000)	$ 74,000	$ 307,000									$ 57,000	$ 0	$ 400,000	$ 0		$ 146,000	$ 188,000	$ 467,000	$ 440,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross																			75,000
Restricted stock granted							62,500	0	255,600	367,643
Restricted stock unit, granted											0	0	137,000							0	0	65,891	69,594	67,000	70,000
Restricted stock, average grant date fair value per share							$ 9.14		$ 14.20	$ 10.42												$ 9.03	$ 10.25	$ 15.17	$ 7.71
Discount rate from market value on offering date																		85.00%
Restricted stock unit vesting period (in years)														1 year

XML

Balance Sheet Details

9 Months Ended

Sep. 30, 2014

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Details

Balance Sheet Details (in thousands)

Inventories

	September 30, 2014		December 31, 2013
Raw materials and purchased parts	$	23,966	$	16,723
Work-in-process	2,285		2,374
Finished goods	23,455		23,149
Consigned finished goods	2,303		2,490
Total inventories	$	52,009	$	44,736

Goodwill

The change in the carrying amount of goodwill from December 31, 2013 to September 30, 2014 is as follows:

Balance at December 31, 2013	$	25,978
Foreign currency translation adjustments	(1,516		)
Balance at September 30, 2014	$	24,462

Accumulated Other Comprehensive Income

	Foreign Currency Translation Adjustment			Defined Benefit Pension Plan			Accumulated Other Comprehensive Income			Affected Line Items in the Statement of Operations
Balance as of December 31, 2013	$	18,804		$	(1,681	)	$	17,123
Other comprehensive income before reclassification	(6,487		)	—			(6,487		)
Amounts reclassified from accumulated other comprehensive income	—			86			86			Cost of Sales, Selling, General and Administrative and Research and Development Expense
Net other comprehensive income for the nine months ended September 30, 2014	(6,487		)	86			(6,401		)
Balance as of September 30, 2014	$	12,317		$	(1,595	)	$	10,722

XML

Credit Facility (Details Textual) (USD $)	3 Months Ended	12 Months Ended		3 Months Ended	9 Months Ended		9 Months Ended	13 Months Ended	3 Months Ended
	Sep. 30, 2014	Dec. 31, 2011 Revolving Credit Facility [Member]	Dec. 31, 2012 Revolving Credit Facility [Member]	Sep. 30, 2014 Secured Debt [Member]	Sep. 30, 2014 London Interbank Offered Rate (LIBOR) [Member] Revolving Credit Facility [Member]	Sep. 30, 2014 Revolving Credit Facility [Member] Secured Debt [Member]	Sep. 30, 2014 Equipment Term Loan [Member] Secured Debt [Member]	Apr. 30, 2012 Equipment Term Loan [Member] Secured Debt [Member]	Sep. 30, 2014 Equipment Term Loan [Member] London Interbank Offered Rate (LIBOR) [Member] Secured Debt [Member]
Debt Instrument [Line Items]
Revolving line of credit			$ 10,000,000
Line of Credit Facility, Required Pledge of Equity Interests in Subsidiary, Percent	100.00%
Borrowings under credit facility, interest payable description	at either (i) the bank’s prime rate or (ii) LIBOR plus 2.25%			applicable interest rate was LIBOR plus 2.25% (2.5% as of September 30, 2014)
Borrowings under credit facility, interest related to Libor rate					2.25%				2.25%
Equipment term loan number of payments							36 months
Equipment term loan, interest rate					2.50%				2.50%
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage		0.25%
Proceeds from Issuance of Debt								5,000,000
Short-term Debt						$ 3,000,000	$ 978,000

XML

Balance Sheet Details (Details 4) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014
Schedule of accumulated other comprehensive income
Balance as of December 31, 2013	$ 17,123
Other comprehensive loss before reclassification	(6,487)
Net other comprehensive income (loss) for three months ended September 30, 2014	(6,401)
Balance as of September 30, 2014	10,722
Foreign Currency Translation Adjustment [Member]
Schedule of accumulated other comprehensive income
Balance as of December 31, 2013	18,804
Other comprehensive loss before reclassification	(6,487)
Net other comprehensive income (loss) for three months ended September 30, 2014	(6,487)
Balance as of September 30, 2014	12,317
Defined Benefit Pension Plan [Member]
Schedule of accumulated other comprehensive income
Balance as of December 31, 2013	(1,681)
Other comprehensive loss before reclassification	0
Net other comprehensive income (loss) for three months ended September 30, 2014	86
Balance as of September 30, 2014	(1,595)
Selling, General and Administrative Expenses
Schedule of accumulated other comprehensive income
Amounts reclassified from accumulated other comprehensive income (loss)	(86)
Selling, General and Administrative Expenses | Foreign Currency Translation Adjustment [Member]
Schedule of accumulated other comprehensive income
Amounts reclassified from accumulated other comprehensive income (loss)	0
Selling, General and Administrative Expenses | Defined Benefit Pension Plan [Member]
Schedule of accumulated other comprehensive income
Amounts reclassified from accumulated other comprehensive income (loss)	$ (86)

XML

Fair Value Measurements (Details Textual) (USD $)	Sep. 30, 2014
Fair Value Measurements (Textual) [Abstract]
Fair value of derivatives	$ (1,507,000)

XML

Foreign Currency Derivative Instruments (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Schedule of gains (losses) on foreign currency forward contracts
Net gains (loss) on foreign currency forward contracts	$ (2,715)	$ 1,379	$ (3,055)	$ 30
Cost of Sales [Member]
Schedule of gains (losses) on foreign currency forward contracts
Net gains (loss) on foreign currency forward contracts	2	2	7	32
Selling, General and Administrative Expenses
Schedule of gains (losses) on foreign currency forward contracts
Net gains (loss) on foreign currency forward contracts	$ (2,717)	$ 1,377	$ (3,062)	$ (2)

XML

Description of Business and Basis of Presentation

9 Months Ended

Sep. 30, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Business and Basis of Presentation

Description of Business and Basis of Presentation

Description of Business

Maxwell Technologies, Inc. is a Delaware corporation originally incorporated in 1965 under the name Maxwell Laboratories, Inc. In 1983, the Company completed an initial public offering, and in 1996, changed its name to Maxwell Technologies, Inc. The Company is headquartered in San Diego, California, and has three manufacturing facilities located in San Diego, California; Rossens, Switzerland; and Peoria, Arizona. In addition, the Company has two contract manufacturers located in China. Maxwell operates as one operating segment called High Reliability, which is comprised of three product lines:

• Ultracapacitors: The Company’s primary focus, ultracapacitors, are energy storage devices that possess a unique combination of high power density, extremely long operational life and the ability to charge and discharge very rapidly. The Company’s ultracapacitor cells and multi-cell packs and modules provide highly reliable energy storage and power delivery solutions for applications in multiple industries, including transportation, automotive, information technology, renewable energy and industrial electronics.

• High-Voltage Capacitors: The Company’s CONDIS^® high-voltage capacitors are designed and manufactured to perform reliably for decades in all climates. These products include grading and coupling capacitors and capacitive voltage dividers that are used to ensure the safety and reliability of electric utility infrastructure and other applications involving transport, distribution and measurement of high-voltage electrical energy.

• Radiation-Hardened Microelectronic Products: The Company’s radiation-hardened microelectronic products for satellites and spacecraft include single board computers and components, such as high-density memory and power modules. Many of these products incorporate our proprietary RADPAK^® packaging and shielding technology and novel architectures that enable them to withstand the effects of environmental radiation and perform reliably in space.

The Company’s products are designed to perform reliably for the life of the products and systems into which they are integrated. The Company achieves high reliability through the application of proprietary technologies and rigorously controlled design, development, manufacturing and test processes.

Financial Statement Presentation

The accompanying condensed consolidated financial statements include the accounts of Maxwell Technologies, Inc. and its subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). All intercompany transactions and account balances have been eliminated in consolidation. The Company has prepared the accompanying unaudited interim condensed consolidated financial statements in accordance with the instructions to Form 10-Q and the standards of accounting measurement set forth in the Interim Reporting Topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”). Consequently, the Company has not necessarily included in this Form 10-Q all information and footnotes required for audited financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements in this Form 10-Q contain all adjustments (consisting only of normal recurring adjustments, except as otherwise indicated) necessary to present fairly the financial position, results of operations, and cash flows of Maxwell Technologies, Inc. for all periods presented. The results reported in these condensed consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for any subsequent period or for the entire year. These unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and the notes thereto included in the Company’s latest Annual Report on Form 10-K. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted in the accompanying interim consolidated financial statements. The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.

Reclassifications

Certain prior period amounts in the consolidated balance sheets at December 31, 2013 and consolidated statement of cash flows for the nine months ended September 30, 2013 have been reclassified to conform to the current period presentation.These reclassifications do not impact reported net income (loss) and do not otherwise have a material impact on the presentation of the overall financial statements.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts and related disclosures. These estimates include, but are not limited to, assessing the collectability of accounts receivable, applied and unapplied production costs, production capacities, the usage and recoverability of inventories and long-lived assets, including deferred income taxes, the incurrence of warranty obligations, impairment of goodwill and other intangible assets, estimation of the cost to complete certain projects, accruals for estimated losses from legal matters, and estimation of the value of stock-based compensation awards, including the probability that the performance criteria of restricted stock awards will be met.

Valuation Allowance on Deferred Tax Asset

At September 30, 2014, the Company has a cumulative valuation allowance recorded offsetting its worldwide net deferred tax assets of $59.5 million, of which the significant majority represents the valuation allowance on its U.S. net deferred tax asset. The Company has established a valuation allowance against its U.S. federal and state deferred tax assets due to the uncertainty surrounding the realization of such assets. Management periodically evaluates the recoverability of the deferred tax assets and at such time as it is determined that it is more likely than not that U.S. deferred tax assets are realizable, the valuation allowance will be reduced accordingly. Any such release would result in recording a tax benefit that would increase net income in the period the valuation is released.

Warranty Obligation

The Company provides warranties on all product sales. The majority of the Company’s warranties are for one to four years in the normal course of business. The Company accrues for the estimated warranty costs at the time of sale based on historical warranty experience plus any known or expected changes in warranty exposure.

Revenue Recognition

Revenue is derived primarily from the sale of manufactured products directly to customers. Product revenue is recognized, according to the guidelines of the Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin (“SAB”) Numbers 101, Revenue Recognition in Financial Statements, and 104, Revenue Recognition, when all of the following criteria are met: (1) persuasive evidence of an arrangement exists (upon contract signing or receipt of an authorized purchase order from a customer); (2) title passes to the customer at either shipment from the Company’s facilities or receipt at the customer facility, depending on shipping terms; (3) customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collectability is reasonably assured. This policy has been consistently applied from period to period.

Beginning in the fourth quarter of 2011, for three distributors of the Company's products, the Company offered extended payment terms which allowed these distributors to pay the Company after they received payment from their customer, with respect to certain sales transactions. Also beginning in the fourth quarter of 2011, for one other distributor of the Company's products, the Company offered return rights and profit margin protection with respect to certain sales transactions. Therefore, for these four distributors, the Company determined that the revenue recognition criteria of SAB 101 and 104 were not met at the time of shipment, as there was no fixed or determinable price, nor was collection reasonably assured, at least with respect to certain sales transactions. As a result, for the three distributors provided with extended payment terms, which did not provide for a fixed or determinable price, the Company deferred the recognition of revenue on all sales beginning in the fourth quarter of 2011 to the period in which cash is received. For the one distributor provided with return rights and profit margin protection, for which the Company could not estimate exposure, the Company deferred the recognition of revenue on all sales beginning in the fourth quarter of 2011 until the distributor confirmed to the Company that it was not entitled to any further returns or credits. During the third quarter of 2013, this distributor confirmed to the Company that it was not entitled to any further returns or credits, therefore, previously unrecognized revenue related to this distributor was recognized in the quarter ended September 30, 2013. Although the Company had deferred revenue recognition for a significant amount of sales to these four distributors through the quarter ended September 30, 2013, subsequent to this date the amount of deferred revenue related to these distributors has been insignificant.

In addition to the deferred revenue arrangements discussed in the preceding paragraph, revenue is not recognized for sales that do not meet the revenue recognition criteria at the time of sale. Revenue is recognized once all of the criteria for revenue recognition are determined to have been met. For example, if the Company does not believe that collection of the sales price is reasonably assured at the time of sale, it defers revenue recognition until cash is received.

As of September 30, 2014 and December 31, 2013, cumulative sales totaling $3.3 million and $4.5 million, respectively, had not yet been recognized as revenue. The Company has recorded the cost basis of inventory shipped to customers prior to the achievement of the revenue recognition criteria of approximately $2.3 million and $2.5 million at September 30, 2014 and December 31, 2013, respectively, in "inventory" in the consolidated balance sheets.

If the Company receives cash payment from the customer prior to the achievement of the revenue recognition criteria, the amount received from the customer is recorded as deferred revenue in the consolidated balance sheets. Total deferred revenue and customer deposits in the consolidated balance sheets as of September 30, 2014 and December 31, 2013 of $2.8 million and $1.0 million, respectively, relates to cash received from customers on sales for which the revenue recognition criteria had not been achieved, customer advances, as well as other less significant customer arrangements requiring the deferral of revenue.

Net Income (Loss) per Share

In accordance with the Earnings Per Share Topic of the FASB ASC, basic net income (loss) per share is calculated using the weighted average number of common shares outstanding during the period. Diluted net income per share includes the impact of additional common shares that would have been outstanding if potentially dilutive common shares were issued. Potentially dilutive securities are not considered in the calculation of diluted net loss per share, as their inclusion would be anti-dilutive. The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share data):

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2014			2013		2014			2013
Numerator
Net income (loss)	$	(3,292	)	$	6,027	$	(4,154	)	$	9,154
Denominator
Weighted-average common shares outstanding	29,284			28,884		29,146			28,857
Effect of potentially dilutive securities:
Options to purchase common stock	—			35		—			17
Restricted stock awards	—			1		—			4
Restricted stock unit awards	—			20		—			5
Weighted-average common shares outstanding, assuming dilution	29,284			28,940		29,146			28,883
Net income (loss) per share
Basic	$	(0.11	)	$	0.21	$	(0.14	)	$	0.32
Diluted	$	(0.11	)	$	0.21	$	(0.14	)	$	0.32

The following table summarizes instruments that may be convertible into common shares that are not included in the denominator used in the diluted net income (loss) per share calculation because to do so would be anti-dilutive (in thousands):

	Three Months Ended		Nine Months Ended
	September 30,		September 30,
	2014	2013	2014	2013
Outstanding options to purchase common stock	701	543	701	743
Unvested restricted stock awards	543	455	543	455
Unvested restricted stock unit awards	168	—	168	13

Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”). The standard provides companies with a single model for accounting for revenue arising from contracts with customers and supersedes current revenue recognition guidance, including industry-specific revenue guidance. The core principle of the model is to recognize revenue when control of the goods or services transfers to the customer, as opposed to recognizing revenue when the risks and rewards transfer to the customer under the existing revenue guidance. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016. Early adoption is not permitted. The guidance permits companies to either apply the requirements retrospectively to all prior periods presented, or apply the requirements in the year of adoption, through a cumulative adjustment.  The Company is in the process of evaluating the impact of adoption on its consolidated financial statements.

In August 2014, the FASB issued ASU No. 2014-15, Disclosure of Uncertainties About an Entity’s Ability to Continue as a Going Concern. The standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued and provides guidance on determining when and how to disclose going concern uncertainties in the financial statements. Certain disclosures will be required if conditions give rise to substantial doubt about an entity’s ability to continue as a going concern. ASU 2014-15 applies to all entities and is effective for annual and interim reporting periods ending after December 15, 2016, with early adoption permitted. The Company does not expect that the adoption of this standard will have a material effect on its financial statements.

XML

Foreign Currency Derivative Instruments (Details 1) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Schedule of foreign currency gains and losses on underlying assets and liabilities
Net gains (loss) on foreign currency forward contracts were partially offset on assets and liabilities	$ 2,721	$ (1,548)	$ 2,505	$ (531)
Cost of Sales [Member]
Schedule of foreign currency gains and losses on underlying assets and liabilities
Net gains (loss) on foreign currency forward contracts were partially offset on assets and liabilities	(12)	(3)	(8)	(28)
Selling, General and Administrative Expenses
Schedule of foreign currency gains and losses on underlying assets and liabilities
Net gains (loss) on foreign currency forward contracts were partially offset on assets and liabilities	$ 2,733	$ (1,545)	$ 2,513	$ (503)

XML

Defined Benefit Plan (Details Textual) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Defined Benefit Plan (Textual) [Abstract]
Employer contributions	$ 182	$ 178	$ 553	$ 539
Additional employer contributions, expected to be paid during the remainder of fiscal year			$ 152

XML

Condensed Consolidated Balance Sheets (Unaudited) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Current assets :
Cash and cash equivalents	$ 30,798	$ 30,647
Trade and other accounts receivable, net of allowance for doubtful accounts of $107 and $134, at September 30, 2014 and December 31, 2013, respectively	30,636	29,869
Inventories	52,009	44,736
Prepaid expenses and other current assets	2,779	2,314
Total current assets	116,222	107,566
Property and equipment, net	41,018	44,941
Goodwill	24,462	25,978
Pension asset	10,576	10,568
Other non-current assets	878	1,034
Total assets	193,156	190,087
Current liabilities:
Accounts payable and accrued liabilities	30,696	25,616
Accrued employee compensation	10,270	8,788
Deferred revenue and customer deposits	2,826	1,043
Short-term borrowings and current portion of long-term debt	9,280	7,914
Deferred tax liability	813	890
Total current liabilities	53,885	44,251
Deferred tax liability, long-term	2,008	2,125
Long-term debt, excluding current portion	44	100
Other long-term liabilities	3,201	3,401
Total liabilities	59,138	49,877
Commitments and contingencies (Note 9)
Stockholders' equity:
Common stock, $0.10 par value per share, 40,000 shares authorized; 29,838 and 29,563 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively	2,983	2,953
Additional paid-in capital	276,261	271,928
Accumulated deficit	(155,948)	(151,794)
Accumulated other comprehensive income	10,722	17,123
Total stockholders' equity	134,018	140,210
Total liabilities and stockholders' equity	$ 193,156	$ 190,087

XML

Condensed Consolidated Statements of Comprehensive Income Loss (Unaudited) (Parenthetical) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Statement of Comprehensive Income [Abstract]
Tax benefit (provision) for amortization of deferred loss	$ 0	$ 7	$ 0	$ 21
Tax benefit (provision) for amortization of prior service cost	$ 7	$ 1	$ 21	$ 7

XML

Stock Plans (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Schedule of stock-based compensation expense
Share-based Compensation			$ 2,934,000	$ 2,622,000
Allocated Share-based Compensation Expense	1,011,000	719,000	2,934,000	2,622,000
Restricted Stock [Member]
Schedule of stock-based compensation expense
Share-based Compensation	703,000	563,000	1,854,000	1,875,000
Restricted Stock Unit
Schedule of stock-based compensation expense
Share-based Compensation	85,000	0	139,000	0
Service-based restricted stock [Member] | Restricted Stock [Member]
Schedule of stock-based compensation expense
Share-based Compensation	696,000	523,000	1,834,000	1,793,000
Service-based restricted stock [Member] | Restricted Stock Unit
Schedule of stock-based compensation expense
Share-based Compensation	51,000	0	83,000	0
Performance-based restricted stock [Member] | Restricted Stock [Member]
Schedule of stock-based compensation expense
Share-based Compensation	7,000	40,000	20,000	82,000
Performance-based restricted stock [Member] | Restricted Stock Unit
Schedule of stock-based compensation expense
Share-based Compensation	34,000	0	56,000	0
Cost of revenue
Schedule of stock-based compensation expense
Allocated Share-based Compensation Expense	145,000	228,000	587,000	762,000
Selling, General and Administrative Expenses
Schedule of stock-based compensation expense
Allocated Share-based Compensation Expense	716,000	332,000	1,705,000	1,337,000
Research and development [Member]
Schedule of stock-based compensation expense
Allocated Share-based Compensation Expense	$ 150,000	$ 159,000	$ 642,000	$ 523,000

XML

Defined Benefit Plan (Tables)

9 Months Ended

Sep. 30, 2014

Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]

Schedule of components of net periodic pension income

Components of net periodic pension (benefit) cost are as follows (in thousands):

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2014			2013			2014			2013
Service cost	$	211		$	207		$	645		$	618
Interest cost	174			125			532			374
Expected return on plan assets	(446		)	(383		)	(1,361		)	(1,145		)
Prior service cost amortization	35			11			107			33
Deferred loss amortization	—			45			—			135
Net periodic pension cost (benefit)	$	(26	)	$	5		$	(77	)	$	15

XML

Stock Plans (Details 1) (USD $)	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2014
Employee Stock [Member]
Schedule of stock options and employee stock purchase plan weighted-average assumptions
Expected dividends	0.00%	0.00%
Exercise price	$ 8.72	$ 8.09
Expected volatility	61.00%	68.00%
Average risk-free interest rate	0.02%	0.05%
Expected life/term (in years)	3 months	6 months
Fair value per share	$ 2.37	$ 5.89
Restricted Stock Unit
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value		$ 15.03
Schedule of stock options and employee stock purchase plan weighted-average assumptions
Expected dividends		0.00%
Expected volatility		65.00%
Average risk-free interest rate		1.00%
Fair value per share		$ 7.71

XML

Description of Business and Basis of Presentation (Details 1) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Outstanding options to purchase common stock
Schedule of instruments convertible into common shares that are not included in the denominator used in the diluted net income (loss) per share calculation because to do so would be anti-dilutive
Anti-dilutive, shares	701	543	701	743
Restricted Stock Awards
Schedule of instruments convertible into common shares that are not included in the denominator used in the diluted net income (loss) per share calculation because to do so would be anti-dilutive
Anti-dilutive, shares	543	455	543	455
Restricted Stock Unit
Schedule of instruments convertible into common shares that are not included in the denominator used in the diluted net income (loss) per share calculation because to do so would be anti-dilutive
Anti-dilutive, shares	168	0	168	13

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
OPERATING ACTIVITIES:
Net income (loss)	$ (4,154)	$ 9,154
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation	8,267	6,518
Amortization of intangible assets	153	247
Amortization of debt discount and prepaid debt costs	15	46
Pension cost (benefit)	(77)	15
Stock-based compensation expense	2,934	2,622
Recoveries of losses on accounts receivable	(27)	(24)
Provision for losses on inventory	604	1,386
Provision for warranties	594	72
Changes in operating assets and liabilities:
Trade and other accounts receivable	(1,294)	4,081
Inventories	(8,171)	(2,247)
Prepaid expenses and other assets	(538)	(82)
Pension asset	(554)	(649)
Accounts payable and accrued liabilities	4,906	1,944
Deferred revenue and customer deposits	2,158	(3,814)
Accrued employee compensation	1,561	3,570
Deferred tax liability, long term	0	(8)
Other long-term liabilities	(126)	1,235
Net cash provided by (used in) operating activities	6,251	24,066
INVESTING ACTIVITIES:
Purchase of property and equipment	(5,195)	(11,716)
Restricted cash	0	(2,300)
Net cash used in investing activities	(5,195)	(14,016)
FINANCING ACTIVITIES:
Principal payments on long-term debt and short-term borrowings	(4,626)	(7,782)
Proceeds from long-term and short-term borrowings	6,292	6,475
Repurchase of shares	0	(47)
Proceeds from issuance of common stock under equity compensation plans	1,430	305
restricted cash - compensating balance	0	(1,750)
Net cash provided by (used in) financing activities	3,096	(2,799)
Increase (decrease) in cash and cash equivalents from operations	4,152	7,251
Effect of exchange rate changes on cash and cash equivalents	(4,001)	1,057
Increase (decrease) in cash and cash equivalents	151	8,308
Cash and cash equivalents, beginning of period	30,647	28,739
Cash and cash equivalents, end of period	$ 30,798	$ 37,047

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $) In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]
Trade and other accounts receivable, allowance	$ 107	$ 134
Common stock, par value	$ 0.10	$ 0.1000
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	29,838,000	29,563,000
Common stock, shares outstanding	29,838,000	29,563,000

XML

Description of Business and Basis of Presentation (Policies)

9 Months Ended

Sep. 30, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Financial Statement Presentation

Financial Statement Presentation

The accompanying condensed consolidated financial statements include the accounts of Maxwell Technologies, Inc. and its subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). All intercompany transactions and account balances have been eliminated in consolidation. The Company has prepared the accompanying unaudited interim condensed consolidated financial statements in accordance with the instructions to Form 10-Q and the standards of accounting measurement set forth in the Interim Reporting Topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”). Consequently, the Company has not necessarily included in this Form 10-Q all information and footnotes required for audited financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements in this Form 10-Q contain all adjustments (consisting only of normal recurring adjustments, except as otherwise indicated) necessary to present fairly the financial position, results of operations, and cash flows of Maxwell Technologies, Inc. for all periods presented. The results reported in these condensed consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for any subsequent period or for the entire year. These unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and the notes thereto included in the Company’s latest Annual Report on Form 10-K. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted in the accompanying interim consolidated financial statements. The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.

Reclassifications

Reclassifications

Certain prior period amounts in the consolidated balance sheets at December 31, 2013 and consolidated statement of cash flows for the nine months ended September 30, 2013 have been reclassified to conform to the current period presentation.These reclassifications do not impact reported net income (loss) and do not otherwise have a material impact on the presentation of the overall financial statements.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts and related disclosures. These estimates include, but are not limited to, assessing the collectability of accounts receivable, applied and unapplied production costs, production capacities, the usage and recoverability of inventories and long-lived assets, including deferred income taxes, the incurrence of warranty obligations, impairment of goodwill and other intangible assets, estimation of the cost to complete certain projects, accruals for estimated losses from legal matters, and estimation of the value of stock-based compensation awards, including the probability that the performance criteria of restricted stock awards will be met.

Income Tax Disclosure

Valuation Allowance on Deferred Tax Asset

At September 30, 2014, the Company has a cumulative valuation allowance recorded offsetting its worldwide net deferred tax assets of $59.5 million, of which the significant majority represents the valuation allowance on its U.S. net deferred tax asset. The Company has established a valuation allowance against its U.S. federal and state deferred tax assets due to the uncertainty surrounding the realization of such assets. Management periodically evaluates the recoverability of the deferred tax assets and at such time as it is determined that it is more likely than not that U.S. deferred tax assets are realizable, the valuation allowance will be reduced accordingly. Any such release would result in recording a tax benefit that would increase net income in the period the valuation is released.

Warranty Obligation

Warranty Obligation

The Company provides warranties on all product sales. The majority of the Company’s warranties are for one to four years in the normal course of business. The Company accrues for the estimated warranty costs at the time of sale based on historical warranty experience plus any known or expected changes in warranty exposure.

Revenue Recognition

Revenue Recognition

Revenue is derived primarily from the sale of manufactured products directly to customers. Product revenue is recognized, according to the guidelines of the Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin (“SAB”) Numbers 101, Revenue Recognition in Financial Statements, and 104, Revenue Recognition, when all of the following criteria are met: (1) persuasive evidence of an arrangement exists (upon contract signing or receipt of an authorized purchase order from a customer); (2) title passes to the customer at either shipment from the Company’s facilities or receipt at the customer facility, depending on shipping terms; (3) customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collectability is reasonably assured. This policy has been consistently applied from period to period.

Beginning in the fourth quarter of 2011, for three distributors of the Company's products, the Company offered extended payment terms which allowed these distributors to pay the Company after they received payment from their customer, with respect to certain sales transactions. Also beginning in the fourth quarter of 2011, for one other distributor of the Company's products, the Company offered return rights and profit margin protection with respect to certain sales transactions. Therefore, for these four distributors, the Company determined that the revenue recognition criteria of SAB 101 and 104 were not met at the time of shipment, as there was no fixed or determinable price, nor was collection reasonably assured, at least with respect to certain sales transactions. As a result, for the three distributors provided with extended payment terms, which did not provide for a fixed or determinable price, the Company deferred the recognition of revenue on all sales beginning in the fourth quarter of 2011 to the period in which cash is received. For the one distributor provided with return rights and profit margin protection, for which the Company could not estimate exposure, the Company deferred the recognition of revenue on all sales beginning in the fourth quarter of 2011 until the distributor confirmed to the Company that it was not entitled to any further returns or credits. During the third quarter of 2013, this distributor confirmed to the Company that it was not entitled to any further returns or credits, therefore, previously unrecognized revenue related to this distributor was recognized in the quarter ended September 30, 2013. Although the Company had deferred revenue recognition for a significant amount of sales to these four distributors through the quarter ended September 30, 2013, subsequent to this date the amount of deferred revenue related to these distributors has been insignificant.

In addition to the deferred revenue arrangements discussed in the preceding paragraph, revenue is not recognized for sales that do not meet the revenue recognition criteria at the time of sale. Revenue is recognized once all of the criteria for revenue recognition are determined to have been met. For example, if the Company does not believe that collection of the sales price is reasonably assured at the time of sale, it defers revenue recognition until cash is received.

As of September 30, 2014 and December 31, 2013, cumulative sales totaling $3.3 million and $4.5 million, respectively, had not yet been recognized as revenue. The Company has recorded the cost basis of inventory shipped to customers prior to the achievement of the revenue recognition criteria of approximately $2.3 million and $2.5 million at September 30, 2014 and December 31, 2013, respectively, in "inventory" in the consolidated balance sheets.

If the Company receives cash payment from the customer prior to the achievement of the revenue recognition criteria, the amount received from the customer is recorded as deferred revenue in the consolidated balance sheets. Total deferred revenue and customer deposits in the consolidated balance sheets as of September 30, 2014 and December 31, 2013 of $2.8 million and $1.0 million, respectively, relates to cash received from customers on sales for which the revenue recognition criteria had not been achieved, customer advances, as well as other less significant customer arrangements requiring the deferral of revenue.

Net Income (Loss) per Share

Net Income (Loss) per Share

In accordance with the Earnings Per Share Topic of the FASB ASC, basic net income (loss) per share is calculated using the weighted average number of common shares outstanding during the period. Diluted net income per share includes the impact of additional common shares that would have been outstanding if potentially dilutive common shares were issued. Potentially dilutive securities are not considered in the calculation of diluted net loss per share, as their inclusion would be anti-dilutive.

Derivatives and Hedging

Maxwell uses forward contracts to hedge certain monetary assets and liabilities, primarily receivables and payables, denominated in foreign currencies. The change in fair value of these forward contracts represents a natural hedge as gains and losses on these instruments partially offset the changes in the fair value of the underlying monetary assets and liabilities due to movements in currency exchange rates. These forward contracts generally expire in one month. These contracts are considered economic hedges but are not designated as hedges under the Derivatives and Hedging Topic of the FASB ASC, therefore, the change in the fair value of the instrument is recognized each period in the consolidated statement of operations.

Fair Value Measurements and Disclosures

The Company records certain financial instruments at fair value in accordance with the Fair Value Measurements and Disclosures Topic of the FASB ASC. As of September 30, 2014, the financial instruments to which this topic applied were foreign currency forward contracts. As of September 30, 2014, the fair value of these foreign currency forward contracts was a liability of $1.5 million which is recorded in “accounts payable and accrued liabilities" in the consolidated balance sheet. The fair value of these derivative instruments is measured using models following quoted market prices in active markets for identical instruments, which is a Level 2 input under the fair value hierarchy of the Fair Value Measurements and Disclosures Topic of the FASB ASC.

XML

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Oct. 21, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	MAXWELL TECHNOLOGIES INC
Entity Central Index Key	0000319815
Document Type	10-Q
Document Period End Date	Sep. 30, 2014
Amendment Flag	false
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q3
Trading Symbol	mxwl
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		29,851,842

XML

Description of Business and Basis of Presentation (Tables)

9 Months Ended

Sep. 30, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of computation of basic and diluted net income (loss) per share

The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share data):

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2014			2013		2014			2013
Numerator
Net income (loss)	$	(3,292	)	$	6,027	$	(4,154	)	$	9,154
Denominator
Weighted-average common shares outstanding	29,284			28,884		29,146			28,857
Effect of potentially dilutive securities:
Options to purchase common stock	—			35		—			17
Restricted stock awards	—			1		—			4
Restricted stock unit awards	—			20		—			5
Weighted-average common shares outstanding, assuming dilution	29,284			28,940		29,146			28,883
Net income (loss) per share
Basic	$	(0.11	)	$	0.21	$	(0.14	)	$	0.32
Diluted	$	(0.11	)	$	0.21	$	(0.14	)	$	0.32

Schedule of instruments convertible into common shares that are not included in the denominator used in the diluted net income (loss) per share calculation because to do so would be anti-dilutive

The following table summarizes instruments that may be convertible into common shares that are not included in the denominator used in the diluted net income (loss) per share calculation because to do so would be anti-dilutive (in thousands):

	Three Months Ended		Nine Months Ended
	September 30,		September 30,
	2014	2013	2014	2013
Outstanding options to purchase common stock	701	543	701	743
Unvested restricted stock awards	543	455	543	455
Unvested restricted stock unit awards	168	—	168	13

XML

Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Statement [Abstract]
Revenue	$ 41,593	$ 51,197	$ 133,668	$ 154,555
Cost of revenue	26,123	30,084	83,728	93,636
Gross profit	15,470	21,113	49,940	60,919
Operating expenses:
Selling, general and administrative	10,823	9,455	32,706	32,945
Research and development	6,923	5,450	19,317	16,851
Total operating expenses	17,746	14,905	52,023	49,796
Income (loss) from operations	(2,276)	6,208	(2,083)	11,123
Interest expense, net	49	36	116	121
Amortization of debt discount and prepaid debt costs	5	16	15	46
Income (loss) from operations before income taxes	(2,330)	6,156	(2,214)	10,956
Income tax provision	962	129	1,940	1,802
Net income (loss)	$ (3,292)	$ 6,027	$ (4,154)	$ 9,154
Net income (loss) per share:
Basic	$ (0.11)	$ 0.21	$ (0.14)	$ 0.32
Diluted	$ (0.11)	$ 0.21	$ (0.14)	$ 0.32
Weighted average common shares outstanding:
Basic	29,284	28,884	29,146	28,857
Diluted	29,284	28,940	29,146	28,883

XML

Foreign Currency Derivative Instruments

9 Months Ended

Sep. 30, 2014

Foreign Currency Derivatives [Abstract]

Foreign Currency Derivative Instruments

Foreign Currency Derivative Instruments

Maxwell uses forward contracts to hedge certain monetary assets and liabilities, primarily receivables and payables, denominated in foreign currencies. The change in fair value of these forward contracts represents a natural hedge as gains and losses on these instruments partially offset the changes in the fair value of the underlying monetary assets and liabilities due to movements in currency exchange rates. These forward contracts generally expire in one month. These contracts are considered economic hedges but are not designated as hedges under the Derivatives and Hedging Topic of the FASB ASC, therefore, the change in the fair value of the instrument is recognized each period in the consolidated statement of operations.

The net gains and losses on foreign currency forward contracts included in cost of revenue and selling, general and administrative expense are as follows (in thousands):

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2014			2013		2014			2013
Cost of revenue	$	2		$	2	$	7		$	32
Selling, general and administrative	(2,717		)	1,377		(3,062		)	(2		)
Total gain (loss)	$	(2,715	)	$	1,379	$	(3,055	)	$	30

The net gains and losses on foreign currency forward contracts were partially offset by net gains and losses on the underlying monetary assets and liabilities. Foreign currency gains and losses on those underlying monetary assets and liabilities included in cost of revenue and selling, general and administrative expense are as follows (in thousands):

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2014			2013			2014			2013
Cost of revenue	$	(12	)	$	(3	)	$	(8	)	$	(28	)
Selling, general and administrative	2,733			(1,545		)	2,513			(503		)
Total gain (loss)	$	2,721		$	(1,548	)	$	2,505		$	(531	)

As of September 30, 2014, the total notional amount of foreign currency forward contracts not designated as hedges was $35.0 million.

The following table presents gross amounts, amounts offset and net amounts presented in the condensed consolidated balance sheets for the Company's derivative instruments measured at fair value (in thousands):

	September 30, 2014			December 31, 2013
Gross amounts of recognized assets (liabilities)	$	(1,668	)	$	472
Gross amounts offset in the condensed consolidated balance sheets	161			(90		)
Net amount of recognized asset (liability) presented in the condensed consolidated balance sheets	$	(1,507	)	$	382

The Company has the legal right to offset these recognized assets and liabilities upon settlement of the derivative instruments. For additional information, refer to Note 4 – Fair Value Measurements.

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2014

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

The Company records certain financial instruments at fair value in accordance with the Fair Value Measurements and Disclosures Topic of the FASB ASC. As of September 30, 2014, the financial instruments to which this topic applied were foreign currency forward contracts. As of September 30, 2014, the fair value of these foreign currency forward contracts was a liability of $1.5 million which is recorded in “accounts payable and accrued liabilities" in the consolidated balance sheet. The fair value of these derivative instruments is measured using models following quoted market prices in active markets for identical instruments, which is a Level 2 input under the fair value hierarchy of the Fair Value Measurements and Disclosures Topic of the FASB ASC. All forward contracts as of September 30, 2014 have approximately a one-month original maturity term and mature on October 2, 2014 or November 4, 2014.

The carrying value of short-term and long-term borrowings approximates fair value because of the relative short maturity of these instruments and the interest rates the Company could currently obtain.

XML

Description of Business and Basis of Presentation (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Schedule of computation of basic and diluted net income (loss) per share
Net income	$ (3,292)	$ 6,027	$ (4,154)	$ 9,154
Effect of assumed conversion of convertible debentures
Weighted-average common shares outstanding	29,284	28,884	29,146	28,857
Weighted-average common shares outstanding, assuming dilution	29,284	28,940	29,146	28,883
Net income per share
Basic	$ (0.11)	$ 0.21	$ (0.14)	$ 0.32
Diluted	$ (0.11)	$ 0.21	$ (0.14)	$ 0.32
Stock Options
Effect of assumed conversion of convertible debentures
Effect of potentially dilutive securities	0	35	0	17
Restricted Stock [Member]
Effect of assumed conversion of convertible debentures
Effect of potentially dilutive securities	0	1	0	4
Restricted Stock Unit
Effect of assumed conversion of convertible debentures
Effect of potentially dilutive securities	0	20	0	5

XML

Balance Sheet Details (Tables)

9 Months Ended

Sep. 30, 2014

Balance Sheet Related Disclosures [Abstract]

Schedule of inventories

	September 30, 2014		December 31, 2013
Raw materials and purchased parts	$	23,966	$	16,723
Work-in-process	2,285		2,374
Finished goods	23,455		23,149
Consigned finished goods	2,303		2,490
Total inventories	$	52,009	$	44,736

Schedule of change in the carrying amount of goodwill

The change in the carrying amount of goodwill from December 31, 2013 to September 30, 2014 is as follows:

Balance at December 31, 2013	$	25,978
Foreign currency translation adjustments	(1,516		)
Balance at September 30, 2014	$	24,462

Schedule of accumulated other comprehensive income

	Foreign Currency Translation Adjustment			Defined Benefit Pension Plan			Accumulated Other Comprehensive Income			Affected Line Items in the Statement of Operations
Balance as of December 31, 2013	$	18,804		$	(1,681	)	$	17,123
Other comprehensive income before reclassification	(6,487		)	—			(6,487		)
Amounts reclassified from accumulated other comprehensive income	—			86			86			Cost of Sales, Selling, General and Administrative and Research and Development Expense
Net other comprehensive income for the nine months ended September 30, 2014	(6,487		)	86			(6,401		)
Balance as of September 30, 2014	$	12,317		$	(1,595	)	$	10,722

XML

Defined Benefit Plan

9 Months Ended

Sep. 30, 2014

Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]

Defined Benefit Plan

Defined Benefit Plan

Maxwell SA, the Company's Swiss subsidiary, has a retirement plan that is classified as a defined benefit pension plan. The employee pension benefit is based on compensation, length of service and credited investment earnings. The plan guarantees both a minimum rate of return as well as minimum annuity purchase rates. The Company’s funding policy with respect to the pension plan is to contribute the amount required by Swiss law, using the required percentage applied to the employee’s compensation. In addition, participating employees are required to contribute to the pension plan. This plan has a measurement date of December 31.

Components of net periodic pension (benefit) cost are as follows (in thousands):

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2014			2013			2014			2013
Service cost	$	211		$	207		$	645		$	618
Interest cost	174			125			532			374
Expected return on plan assets	(446		)	(383		)	(1,361		)	(1,145		)
Prior service cost amortization	35			11			107			33
Deferred loss amortization	—			45			—			135
Net periodic pension cost (benefit)	$	(26	)	$	5		$	(77	)	$	15

Employer contributions of $182,000 and $178,000 were paid during the three months ended September 30, 2014 and 2013, respectively. Employer contributions of $553,000 and $539,000 were paid during the nine months ended September 30, 2014 and 2013, respectively. Additional employer contributions of approximately $152,000 are expected to be paid during the remainder of fiscal 2014.

XML

Stock Plans

9 Months Ended

Sep. 30, 2014

Share-based Compensation [Abstract]

Stock Plans

Stock Plans

The Company has two active stock-based compensation plans as of September 30, 2014: the 2004 Employee Stock Purchase Plan and the 2013 Omnibus Equity Incentive Plan under which incentive stock options, non-qualified stock options, restricted stock awards and restricted stock units can be granted to employees and non-employee directors.

Stock Options

Beginning in 2011, the Company ceased granting stock options to employees as part of its annual equity incentive award program. However, during the three months ended June 30, 2013, the Company granted 75,000 stock options to its former chief operating officer upon his initial engagement with vesting in equal annual installments over four years from the date of grant. Unvested options were cancelled upon his resignation in the third quarter of 2014. The Company may determine to grant stock options in the future to employees as part of its annual equity incentive award program. Compensation expense recognized from employee stock options for the three months ended September 30, 2014 and 2013 was $33,000 and a benefit of $32,000, respectively, and $74,000 and $307,000, respectively, for the nine months ended September 30, 2014 and 2013.

Restricted Stock Awards

Beginning in the second quarter of 2014, the Company ceased granting restricted stock awards and began granting restricted stock units to employees as part of its annual equity incentive award program. During the three months ended September 30, 2013, the Company granted 62,500 shares under restricted stock awards which had an average grant date fair value per share of $9.14. During the nine months ended September 30, 2014 and 2013 the Company granted 255,600 and 367,643 shares, respectively, under restricted stock awards, which had an average grant date fair value per share of $14.20 and $10.42, respectively. The following table summarizes the amount of compensation expense recognized for restricted stock awards for the three and nine months endedSeptember 30, 2014 and 2013 (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Service-based restricted stock awards	$	696	$	523	$	1,834	$	1,793
Performance-based restricted stock awards	7		40		20		82
Total compensation expense recognized for restricted stock awards	$	703	$	563	$	1,854	$	1,875

Restricted Stock Units

Non-employee director restricted stock units

Non-employee directors receive an annual restricted stock unit award, normally in February of each year, as part of their annual retainer compensation, which vests one year from the date of grant. Each restricted stock unit represents the right to receive one unrestricted share of the Company’s common stock upon vesting. During the three months ended September 30, 2014 and 2013, no restricted stock units were granted to non-employee directors. During the nine months endedSeptember 30, 2014 and 2013, non-employee directors were granted a total of 65,891 and 69,594 restricted stock units, respectively, with an average grant date fair value per share of $9.03 and $10.25, respectively. Compensation expense recognized for non-employee director restricted stock units for the three months ended September 30, 2014 and 2013 was $146,000 and $188,000, respectively, and $467,000 and $440,000, respectively, for the nine months ended September 30, 2014 and 2013.

Employee restricted stock units

Beginning in the second quarter of 2014, the Company ceased granting restricted stock awards and began granting restricted stock units to employees as part of its annual equity incentive award program. Each restricted stock unit represents the right to receive one unrestricted share of the Company’s common stock upon vesting. During the three months ended September 30, 2014, the Company did not grant any restricted stock units. During the nine months endedSeptember 30, 2014, the Company granted 137,000 restricted stock units to employees of which 67,000 were service-based restricted stock units vesting in equal installments over four years of continuous service with an average grant date value of $15.17 per share, and 70,000 were market-condition restricted stock units vesting upon the achievement of certain stock price thresholds and the completion of three years of continuous employment from the date of grant with an average grant date fair value of $7.71 per share. Since the vesting of the market-condition restricted stock units is dependent on stock price performance, the fair values of these awards were estimated using a Monte-Carlo valuation model with the following weighted-average assumptions:

Market price at grant per share	$	15.03
Expected dividends	$	—
Expected volatility	65		%
Risk-free interest rate	0.86		%
Fair value per unit	$	7.71

The following table summarizes the amount of compensation expense recognized for employee restricted stock units for the three and nine months endedSeptember 30, 2014 and 2013 (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Service-based restricted stock units	$	51	$	—	$	83	$	—
Market-condition restricted stock units	34		—		56		—
Total compensation expense recognized for employee restricted stock units	$	85	$	—	$	139	$	—

Employee Stock Purchase Plan

The 2004 Employee Stock Purchase Plan (“ESPP”) permits substantially all employees to purchase common stock through payroll deductions, at 85% of the lower of the trading price of the stock at the beginning or at the end of each six month offering period commencing on January 1 and July 1. The number of shares purchased is based on participants’ contributions made during the offering period.

Compensation expense recognized for the ESPP for the three and nine months ended September 30, 2014 was $57,000 and $400,000, respectively. For the three and nine months ended September 30, 2013, no compensation expense was recognized for the ESPP as the plan had been temporarily suspended. The fair value of the ESPP shares for the three and nine months ended September 30, 2014 was estimated using the Black-Scholes valuation model for a call and a put option with the following weighted-average assumptions:

	Three Months Ended			Nine Months Ended
	September 30,			September 30,
	2014			2014
Expected dividends	$	—		$	—
Exercise price	$	8.72		$	8.09
Expected volatility	61		%	68		%
Risk-free interest rate	0.02		%	0.05		%
Expected life/term (in years)	0.3			0.5
Fair value per share	$	2.37		$	5.89

Stock-Based Compensation Expense

Compensation cost for restricted stock awards, restricted stock units, stock options and the ESPP included in cost of revenue; selling, general and administrative expense; and research and development expense is as follows (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Cost of revenue	$	145	$	228	$	587	$	762
Selling, general and administrative	716		332		1,705		1,337
Research and development	150		159		642		523
Total stock-based compensation expense	$	1,011	$	719	$	2,934	$	2,622

XML

Shelf Registration Statement

9 Months Ended

Sep. 30, 2014

Shelf Registration Statement [Abstract]

Shelf Registration Statement

Shelf Registration Statement

On June 3, 2014, the Company filed a shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission ("SEC") to, from time to time, sell up to an aggregate of $125 million of any combination of its common stock, warrants, debt securities or units. On June 30, 2014, the registration statement was declared effective by the SEC, which will allow the Company to access the capital markets for the three year period following this effective date. As of September 30, 2014, no securities have been issued under the Company's shelf registration statement. Net proceeds, terms and pricing of each offering of securities issued under the shelf registration statement will be determined at the time of such offerings.

XML

Legal Proceedings

9 Months Ended

Sep. 30, 2014

Commitments and Contingencies Disclosure [Abstract]

Legal Proceedings

Legal Proceedings

Although the Company expects to incur significant legal fees in connection with the below legal proceedings, the Company is unable to estimate the amount of such legal fees and therefore, such fees will be expensed in the period the legal services are performed.

FCPA Matter

As a result of being publicly traded in the U.S., the Company is subject to the U.S. Foreign Corrupt Practices Act (“FCPA”), which prohibits companies from making improper payments to foreign officials for the purpose of obtaining or retaining business. Beginning in 2009, the Company conducted an internal review into payments made to its former independent sales agent in China with respect to sales of its high voltage capacitor products produced by its Swiss subsidiary. In January 2011, the Company reached settlements with the SEC and the U.S. Department of Justice (“DOJ”) with respect to charges asserted by the SEC and DOJ relating to the anti-bribery, books and records, internal controls, and disclosure provisions of the FCPA and other securities laws violations. The Company settled civil charges with the SEC, agreeing to an injunction against further violations of the FCPA. Under the terms of the settlement with the SEC, the Company agreed to pay a total of approximately $6.4 million in profit disgorgement and prejudgment interest. The Company settled civil and criminal charges with the DOJ by entering into a three-year deferred prosecution agreement (“DPA”) and agreeing to pay a total of $8.0 million in penalties. Further, under the terms of each agreement, the Company has submitted periodic reports to the SEC and DOJ on its internal compliance program concerning anti-bribery. As of January 25, 2013, all monetary penalties had been paid in full for each settlement described above and, in early February 2014, the DPA expired on its own terms. A judgment of dismissal was issued by the District Judge for the matter in the U.S. District Court for the Southern District of California on March 28, 2014.

On October 15, 2013, the Company received an informal notice from the DOJ that an indictment against the former Senior Vice President and General Manager of its Swiss subsidiary had been filed in the United States District Court for the Southern District of California. The indictment is against the individual, a former officer, and not against the Company and the Company does not foresee that further penalties or fines could be assessed against it as a corporate entity for this matter. However, the Company may be required throughout the term of the action to advance the legal fees and costs incurred by the individual defendant and to incur other financial obligations. While the Company maintains directors’ and officers’ insurance policies which are intended to cover legal expenses related to its indemnification obligations in situations such as these, the Company cannot determine if and to what extent the insurance policy will cover the legal fees for this matter. Accordingly, the legal fees that may be incurred by the Company in defending this former officer could have a material impact on its financial condition and results of operation.

Swiss Bribery Matter

In August 2013, the Company's Swiss subsidiary was served with a search warrant from the Swiss federal prosecutor’s office. At the end of the search, the Swiss federal prosecutor presented the Company with a listing of the materials gathered by the representatives and then removed the materials from its premises for keeping at the prosecutor’s office. By reviewing the items to be seized on the search warrant presented by the Swiss prosecutor’s office, the Company believes this action to be related to the same or similar facts and circumstances as the FCPA action previously settled with the SEC and the DOJ. During initial discussions, the Swiss prosecutor has acknowledged both the existence of the Company's DPA with the DOJ and its cooperation efforts thereunder, both of which should have a positive impact on discussions going forward. Additionally, other than the activities previously reviewed in conjunction with the SEC and DOJ matters under the FCPA, the Company has no reason to believe that additional facts or circumstances are under review by the Swiss authorities. At such an early stage in the investigation, the Company is currently unable to determine the extent to which it will be subject to fines in accordance with Swiss bribery laws and what additional expenses will be incurred in order to defend this matter. As such, the Company cannot determine whether there is a reasonable possibility that a loss will be incurred nor can it estimate the range of any such potential loss. Accordingly, the Company has not accrued an amount for any potential loss associated with this action, but an adverse result could have a material adverse impact on its financial condition and results of operation.

Securities Matter

In early 2013, the Company voluntarily provided information to the United States Attorney's Office for the Southern District of California and the U.S. Securities and Exchange Commission related to its announcement that it intended to file restated financial statements for fiscal years 2011 and 2012. The Company is currently cooperating with the US authorities in connection with these investigations. At this preliminary stage, the Company cannot predict the ultimate outcome of this action, nor can it estimate the range of potential loss. Accordingly, the Company has not accrued an amount for any potential loss associated with this action, but an adverse result could have a material adverse impact on its financial condition and results of operation.

Securities Class Action Matter

From March 13, 2013 through April 19, 2013, four purported shareholder class actions were filed in the United States District Court for the Southern District of California against the Company and certain of its current and former officers. These actions were entitled Foster v. Maxwell Technologies, Inc., et al., Case No. 13-cv-0580 (S.D. Cal. filed March 13, 2013), Weinstein v. Maxwell Technologies, Inc., et al., No. 13-cv-0686 (S.D. Cal. filed March 21, 2013), Abanades v. Maxwell Technologies, Inc., et al., No. 13-cv-0867 (S.D. Cal. filed April 11, 2013), and Mebarak v. Maxwell Technologies, Inc., et al., No. 13-cv-0942 (S.D. Cal. filed April 19, 2013). The complaints alleged that the defendants made false and misleading statements regarding its financial performance and business prospects and overstated the Company's reported revenue. The complaints purported to assert claims for violations of Section 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5 on behalf of all persons who purchased the Company's common stock between April 28, 2011 and March 7, 2013, inclusive. The complaints sought unspecified monetary damages and attorneys' fees and costs. On May 13, 2013, four prospective lead plaintiffs filed motions to consolidate the four actions and to be appointed lead plaintiff and, on October 24, 2013, the court issued a written order consolidating the case under the heading In re Maxwell Technologies, Inc., Securities Litigation. On January 16, 2014, the lead plaintiff filed a consolidated and amended complaint which slightly adjusted the class period to April 29, 2011 to March 19, 2013. In response, the Company and the individual defendants filed a motion to dismiss the complaint, which the lead plaintiff opposed. On May 5, 2014, the court granted the Company’s motion to dismiss but granted the lead plaintiff leave to amend its complaint. The lead plaintiff filed an amended complaint on June 4, 2014, and the Company and individual defendants filed motions to dismiss on July 10, 2014. On October 6, 2014, the parties executed a stipulation of settlement, which included an all-in settlement value of $3.3 million. On October 16, 2014, the lead plaintiff filed a motion for preliminary approval of the settlement. As a result of the preliminary settlement, for the quarter ended September 30, 2014, the Company accrued a liability of $3.3 million, which is included in “accounts payable and accrued liabilities,” and a corresponding receivable of $3.3 million, which is included in “trade and other accounts receivable,” as this amount is payable by the Company's insurance carrier.

Federal Shareholder Derivative Matter

On April 23, 2013 and May 7, 2013, two shareholder derivative actions were filed in the United States District Court for the Southern District of California, entitled Kienzle v. Schramm, et al., Case No. 13-cv-0966 (S.D. Cal. filed April 23, 2013) and Agrawal v. Cortes, et al., Case No. 13-cv-1084 (S.D. Cal. filed May 7, 2013). The complaints name as defendants certain of the Company's current and former officers and directors and names the Company as a nominal defendant. The complaints allege that the individual defendants caused or allowed the Company to issue false and misleading statements about its financial condition, operations, management, and internal controls and falsely represented that it maintained adequate controls. The complaints assert causes of action for breach of fiduciary duty, abuse of control, gross mismanagement, waste of corporate assets and unjust enrichment. The lawsuits seek unspecified damages, an order directing the Company to take all necessary actions to reform and improve its corporate governance and internal procedures, restitution and disgorgement of profits, benefits, and other compensation, attorneys' and experts' fees, and costs and expenses. On June 10, 2013, the parties filed a joint motion to consolidate the two actions. On September 26, 2013, the plaintiffs filed a motion to stay this case until the resolution of the similar derivative action pending in the California Superior Court for the County of San Diego. The Company and individual defendants opposed this motion to stay. On October 30, 2013, the court issued two orders consolidating the two cases under the heading In re Maxwell Technologies, Inc. Derivative Litigation, which had been mutually agreed upon by all parties, and denying the plaintiffs’ motion to stay their own federal derivative case. The lead plaintiffs filed their consolidated and amended complaint on January 30, 2014. In response, the Company and the individual defendants filed motions to dismiss the complaint, which the lead plaintiffs opposed. On May 28, 2014, the court granted the Company’s motion to dismiss but granted the lead plaintiffs leave to amend their complaint. The lead plaintiffs filed an amended complaint on July 11, 2014, to which the Company and individual defendants filed motions to dismiss on August 18, 2014. On September 19, 2014, the parties entered a memorandum of understanding concerning settlement of this matter with respect to certain corporate governance reforms to be implemented and/or maintained by the Company. This memorandum of understanding does not address any monetary amounts to be paid to the lead plaintiffs in exchange for the benefit conferred to the Company as a result of the corporate governance reforms. Negotiations have been initiated with respect to the monetary amounts to be paid to lead plaintiffs and such preliminary amounts have been in the range of $650,000 to $1.5 million. As the Company believes that settlement within this range is probable, but does not believe that a specific amount within this range represents a better estimate, the Company accrued a liability for the low end of this range in the amount of $650,000, which is included in “accounts payable and accrued liabilities” for the quarter ended September 30, 2014. As the Company’s insurance carrier would cover this potential settlement, the Company recorded a corresponding receivable from the insurance carrier in the amount of $650,000, which is included in “trade and other accounts receivable,” for the quarter ended September 30, 3014. Pursuant to the status report that the parties submitted to the court on October 6, 2014, the lead plaintiffs will file a motion for preliminary approval of the settlement on or before November 14, 2014.

State Shareholder Derivative Matter

On April 11, 2013 and April 18, 2013, two shareholder derivative actions were filed in California Superior Court for the County of San Diego, entitled Warsh v. Schramm, et al., Case No. 37-2013-00043884 (San Diego Sup. Ct. filed April 11, 2013) and Neville v. Cortes, et al., Case No. 37-2013-00044911-CU-BT-CTL (San Diego Sup. Ct. filed April 18, 2013). The complaints name as defendants certain of the Company's current and former officers and directors as well as its former auditor McGladrey LLP. The Company is named as a nominal defendant. The complaints allege that the individual defendants made or caused the Company to make false and/or misleading statements regarding its financial condition, and failed to disclose material adverse facts about its business, operations and prospects. The complaints assert causes of action for breaches of fiduciary duty for disseminating false and misleading information, failing to maintain internal controls, and failing to properly oversee and manage the Company, as well as for unjust enrichment, abuse of control, gross mismanagement, professional negligence and accounting malpractice, and aiding and abetting breaches of fiduciary duty. The lawsuits seek unspecified damages, an order directing the Company to take all necessary actions to reform and improve its corporate governance and internal procedures, restitution and disgorgement of profits, benefits and other compensation, attorneys' and experts' fees, and costs and expenses. On May 7, 2013, the court consolidated the two actions. The Company filed a motion to stay the consolidated action on July 2, 2013. On September 27, 2013, the court heard oral arguments on the motion to stay and continued the hearing on this motion until the resolution of the motion to stay pending in the federal derivative action referenced above. Given the outcome of the above-detailed federal derivative lawsuit, the Company informed the state court of the federal court order denying the federal plaintiffs’ motion to stay. Consequently, on November 1, 2013, the state court stayed the state derivative action pending before it until the resolution of the federal derivative case. The memorandum of understanding concerning settlement in the federal shareholder derivative matter contemplates that this action will be dismissed with prejudice in the event that settlement is approved by the federal court.

Shareholder Demand Letter Matter

On April 9, 2013, Stephen Neville, a purported shareholder of the Company, sent a demand letter to the Company to inspect its books and records pursuant to California Corporations Code Section 1601. The demand sought inspection of documents related to the Company's March 7, 2013 announcement that it would be restating its previously-issued financial statements for 2011 and 2012, board minutes and committee materials, and other documents related to its board or management discussions regarding revenue recognition from January 1, 2011 to the present. The Company responded by letter dated April 19, 2013, explaining why it believed that the demand did not appear to be proper. Following receipt of a second letter from Mr. Neville dated April 23, 2013, the Company explained by letter dated April 29, 2013 why it continues to believe that the inspection demand appears improper. The Company has not received a further response from Mr. Neville regarding the inspection demand. In conjunction with the state Court derivative action referenced above, Mr. Neville filed two motions to compel production of the documents and materials originally sought in the demand letter. On September 27, 2013, the Court heard oral arguments on the motions to compel and, in line with the continuance on the motion to stay in the state shareholder derivative matter referenced above, likewise continued the hearing on the motions to compel, pending resolution of the motions to stay in both the federal and state derivative actions referenced above. On November 15, 2013, the purported shareholder, Mr. Neville, filed a petition for writ of mandate requesting that the state Court order the Company to comply with the inspection demand. The Company responded to this writ on January 15, 2014, claiming that the inspection demand is improper on numerous grounds and simultaneously filing a demurrer to the shareholder inspection demand action in its entirety. On July 18, 2014, the Court ruled against the Company’s demurrer but left open issues pertaining to the documents to be provided, if any, under the purported shareholder inspection demand. The Court set a further hearing in this matter for April 10, 2015. The memorandum of understanding concerning settlement in the federal shareholder derivative matter contemplates that this action will be dismissed with prejudice in the event that settlement is approved by the federal Court.

XML

Foreign Currency Derivative Instruments Foreign Currency Derivative Instruments (Datails 2) (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Foreign Currency [Abstract]
Derivative Asset, Fair Value, Gross Asset	$ (1,668)	$ 472
Derivative Liability, Fair Value, Gross Asset	161	(90)
Derivative Asset	$ (1,507)	$ 382

XML

Stock Plans (Tables)

9 Months Ended

Sep. 30, 2014

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of stock-based compensation expense

Compensation cost for restricted stock awards, restricted stock units, stock options and the ESPP included in cost of revenue; selling, general and administrative expense; and research and development expense is as follows (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Cost of revenue	$	145	$	228	$	587	$	762
Selling, general and administrative	716		332		1,705		1,337
Research and development	150		159		642		523
Total stock-based compensation expense	$	1,011	$	719	$	2,934	$	2,622

Restricted Stock Awards

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of employee stock purchase plan weighted-average assumptions

The following table summarizes the amount of compensation expense recognized for restricted stock awards for the three and nine months endedSeptember 30, 2014 and 2013 (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Service-based restricted stock awards	$	696	$	523	$	1,834	$	1,793
Performance-based restricted stock awards	7		40		20		82
Total compensation expense recognized for restricted stock awards	$	703	$	563	$	1,854	$	1,875

Restricted Stock Unit

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of employee stock purchase plan weighted-average assumptions

Since the vesting of the market-condition restricted stock units is dependent on stock price performance, the fair values of these awards were estimated using a Monte-Carlo valuation model with the following weighted-average assumptions:

Market price at grant per share	$	15.03
Expected dividends	$	—
Expected volatility	65		%
Risk-free interest rate	0.86		%
Fair value per unit	$	7.71

Schedule of stock-based compensation expense

The following table summarizes the amount of compensation expense recognized for employee restricted stock units for the three and nine months endedSeptember 30, 2014 and 2013 (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Service-based restricted stock units	$	51	$	—	$	83	$	—
Market-condition restricted stock units	34		—		56		—
Total compensation expense recognized for employee restricted stock units	$	85	$	—	$	139	$	—

Employee Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of stock-based compensation expense

The fair value of the ESPP shares for the three and nine months ended September 30, 2014 was estimated using the Black-Scholes valuation model for a call and a put option with the following weighted-average assumptions:

	Three Months Ended			Nine Months Ended
	September 30,			September 30,
	2014			2014
Expected dividends	$	—		$	—
Exercise price	$	8.72		$	8.09
Expected volatility	61		%	68		%
Risk-free interest rate	0.02		%	0.05		%
Expected life/term (in years)	0.3			0.5
Fair value per share	$	2.37		$	5.89

XML

Balance Sheet Details (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Schedule of inventories
Raw material and purchased parts	$ 23,966	$ 16,723
Work-in-process	2,285	2,374
Finished goods	23,455	23,149
Cost of Inventory Shipped	2,303	2,490
Total inventories	$ 52,009	$ 44,736

XML

Legal Proceedings (Details Textual) (USD $)	12 Months Ended	24 Months Ended	3 Months Ended
	Mar. 31, 2012 SEC Penalties Settlement [Member]	Mar. 31, 2013 Doj Penalties Settlement [Member]	Sep. 30, 2014 Securities Class Action Settlement [Member]	Sep. 30, 2014 Federal Shareholder Derivative Settlement [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount	$ 6,400,000	$ 8,000,000	$ 3,300,000
Loss Contingency, Accrual, Current			3,300,000	650,000
Insurance Settlements Receivable, Current			3,300,000	650,000
Loss Contingency, Range of Possible Loss, Minimum				650,000
Loss Contingency, Range of Possible Loss, Maximum				$ 1,500,000

XML

Condensed Consolidated Statements of Comprehensive Income Loss (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (3,292)	$ 6,027	$ (4,154)	$ 9,154
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	(7,119)	3,778	(6,487)	1,391
Defined benefit pension plan, net of tax:
Amortization of deferred loss, net of tax benefit of $7 for the three months ended September 30, 2013, net of tax benefit of $21 for the nine months ended September 30, 2013	0	38	0	114
Amortization of prior service cost, net of tax benefit of $7 and $1 for the three months ended September 30, 2014 and 2013, respectively; net of tax benefit of $21 and $7 for the nine months ended September 30, 2014 and 2013, respectively	28	10	86	28
Other comprehensive income (loss), net of tax	(7,091)	3,826	(6,401)	1,533
Comprehensive income (loss)	$ (10,383)	$ 9,853	$ (10,555)	$ 10,687

XML

Credit Facility

9 Months Ended

Sep. 30, 2014

Debt Disclosure [Abstract]

Credit Facility

Credit Facility

In December 2011, the Company obtained a secured credit facility in the form of a revolving line of credit (the “Revolving Line of Credit”) and an equipment term loan (the “Equipment Term Loan”) (together, the “Credit Facility”). As amended, the Revolving line of Credit was available up to a maximum of $10.0 million. In general, amounts borrowed under the Credit Facility are secured by a lien on all of the Company’s assets other than its intellectual property. In addition, under the credit agreement, as amended, the Company is required to pledge 100% of its equity interests in its Swiss subsidiary. The Company has also agreed not to encumber any of its intellectual property. The agreement contains certain restrictive covenants that limit the Company’s ability to, amongst other things; (i) incur additional indebtedness or guarantees; (ii) create liens or other encumbrances on its property; (iii) enter into a merger or similar transaction; (iv) invest in another entity; (v) declare or pay dividends; and (vi) invest in fixed assets in excess of a defined dollar amount. Repayment of amounts owed pursuant to the Credit Facility may be accelerated in the event that the Company is in violation of any of the representations, warranties and covenants made in the credit agreement, including certain financial covenants. The financial covenants that the Company must meet during the term of the credit agreement, as amended, include quarterly minimum liquidity ratios, minimum cash requirements and net loss targets. Borrowings under the Credit Facility bear interest, payable monthly, at either (i) the bank's prime rate or (ii) LIBOR plus 2.25%, at the Company's option subject to certain limitations. Further, the Company incurs an unused commitment fee, payable quarterly, equal to 0.25% per annum of the average daily unused amount of the Revolving Line of Credit.

The Equipment Term Loan was available to finance 80% of eligible equipment purchases made between April 1, 2011 and April 30, 2012. During this period, the Company borrowed $5.0 million under the Equipment Term Loan. In March 2014, the Company borrowed $3.0 million under the Revolving Line of Credit, and no other amounts have been borrowed to date under the Revolving Line of Credit.

As of December 31, 2013, the Company was not in compliance with the financial covenant pertaining to the quarterly EBITDA target for the quarter ended December 31, 2013. As a result of this noncompliance, borrowings outstanding under the Credit Facility were classified as a current obligation in the consolidated balance sheet as of December 31, 2013.

On August 29, 2014, the Company entered into an amendment to the Credit Facility with the bank where any existing defaults were waived. Under the amendment, the financial covenants that the Company must meet during the term of the credit agreement were revised to include quarterly minimum liquidity ratios, minimum cash requirements and net loss targets.

As of September 30, 2014, the Company was not in compliance with the financial covenant pertaining to the requirement to maintain a quarterly minimum liquidity ratio. As a result of this noncompliance, the bank's obligation to extend any further credit has ceased and terminated and the outstanding debt balance is immediately callable by the bank.

As of September 30, 2014, $1.0 million was outstanding under the Equipment Term Loan and the applicable interest rate was LIBOR plus 2.25% (2.5% as of September 30, 2014). If the bank does not exercise its right to accelerate repayment, under the original terms of the Credit Facility, principal and interest under the Equipment Term Loan are payable in 36 equal monthly installments such that the Equipment Term Loan is fully repaid by the maturity date of April 30, 2015, but may be prepaid in whole or in part at any time. As of September 30, 2014, $3.0 million was outstanding under the Revolving Line of Credit and the applicable interest rate was LIBOR plus 2.25% (2.5% as of September 30, 2014). If the bank does not exercise its right to accelerate repayment, under the amended terms of the Credit Facility, the amount outstanding under the Revolving Line of Credit is scheduled to be repaid by February 28, 2015.

XML

Balance Sheet Details (Details 2) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014
Schedule of change in the carrying amount of goodwill
Balance at December 31, 2013	$ 25,978
Foreign currency translation adjustments	(1,516)
Balance at September 30, 2014	$ 24,462

XML

Shelf Registration Statement (Details Textual) (USD $) In Millions, unless otherwise specified	Jun. 03, 2014
Stock Offering (Textual) [Abstract]
Value of Securities Permitted to be Issued Under Shelf Registration	$ 125

XML

Foreign Currency Derivative Instruments (Tables)

9 Months Ended

Sep. 30, 2014

Foreign Currency Derivatives [Abstract]

Schedule of gains (losses) on foreign currency forward contracts

The net gains and losses on foreign currency forward contracts included in cost of revenue and selling, general and administrative expense are as follows (in thousands):

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2014			2013		2014			2013
Cost of revenue	$	2		$	2	$	7		$	32
Selling, general and administrative	(2,717		)	1,377		(3,062		)	(2		)
Total gain (loss)	$	(2,715	)	$	1,379	$	(3,055	)	$	30

Schedule of foreign currency gains and losses on underlying assets and liabilities

Foreign currency gains and losses on those underlying monetary assets and liabilities included in cost of revenue and selling, general and administrative expense are as follows (in thousands):

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2014			2013			2014			2013
Cost of revenue	$	(12	)	$	(3	)	$	(8	)	$	(28	)
Selling, general and administrative	2,733			(1,545		)	2,513			(503		)
Total gain (loss)	$	2,721		$	(1,548	)	$	2,505		$	(531	)

Offsetting Liabilities

The following table presents gross amounts, amounts offset and net amounts presented in the condensed consolidated balance sheets for the Company's derivative instruments measured at fair value (in thousands):

	September 30, 2014			December 31, 2013
Gross amounts of recognized assets (liabilities)	$	(1,668	)	$	472
Gross amounts offset in the condensed consolidated balance sheets	161			(90		)
Net amount of recognized asset (liability) presented in the condensed consolidated balance sheets	$	(1,507	)	$	382